Axel Heidenreich
#111,588
Most Influential Person Now
Researcher
Axel Heidenreich's AcademicInfluence.com Rankings
Axel Heidenreichcomputer-science Degrees
Computer Science
#4227
World Rank
#4448
Historical Rank
Computational Linguistics
#363
World Rank
#369
Historical Rank
Machine Learning
#766
World Rank
#777
Historical Rank
Artificial Intelligence
#974
World Rank
#992
Historical Rank
Download Badge
Computer Science
Axel Heidenreich's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Axel Heidenreich Influential?
(Suggest an Edit or Addition)Axel Heidenreich's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EAU guidelines on prostate cancer. (2001) (2417)
- EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. (2014) (1877)
- EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (2011) (1449)
- EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. (2011) (1178)
- [EAU guidelines on prostate cancer]. (2009) (1144)
- Guidelines on Prostate Cancer (2013) (927)
- EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. (2014) (861)
- [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. (2011) (733)
- Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. (2002) (632)
- European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. (2008) (556)
- European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). (2004) (476)
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. (2018) (452)
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) (381)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. (2013) (378)
- Pelvic lymph node dissection in prostate cancer. (2009) (344)
- Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. (2007) (324)
- Organ sparing surgery for malignant germ cell tumor of the testis. (2001) (305)
- Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration (2020) (298)
- Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. (2003) (287)
- Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer (2012) (268)
- Prostate Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2020) (260)
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. (2020) (260)
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (2015) (256)
- Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours (2000) (251)
- Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial. (2016) (242)
- Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013) (241)
- Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial. (2019) (230)
- Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. (2011) (229)
- Modern approach of diagnosis and management of acute flank pain: review of all imaging modalities. (2002) (213)
- The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. (2011) (210)
- The Y deletion gr/gr and susceptibility to testicular germ cell tumor. (2005) (208)
- ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up (2018) (205)
- Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study. (2015) (199)
- Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial. (2013) (197)
- Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. (2014) (192)
- European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. (2008) (191)
- Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. (2016) (191)
- Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. (2003) (191)
- Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen. (2017) (180)
- Focal therapy in prostate cancer-report from a consensus panel. (2010) (179)
- Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. (2009) (178)
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. (2019) (174)
- Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study (2019) (174)
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. (2012) (174)
- Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. (2010) (173)
- Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations (2018) (172)
- Organ-sparing surgery for adult testicular tumours: a systematic review of the literature. (2010) (165)
- Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score (2016) (165)
- Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. (2014) (165)
- Early detection of prostate cancer: European Association of Urology recommendation. (2013) (151)
- Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. (2014) (147)
- High-risk prostate cancer: from definition to contemporary management. (2012) (146)
- Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. (2011) (137)
- Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial. (2003) (137)
- Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. (2008) (134)
- Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. (2006) (133)
- Accuracy of frozen section examination of testicular tumors of uncertain origin. (2002) (132)
- Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with 68Ga-PSMA-HBED-CC than with 18F-Fluoroethylcholine PET/CT (2016) (131)
- The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. (2014) (130)
- PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer (2017) (126)
- Preoperative imaging in renal cell cancer (2004) (126)
- Risk Factors for Antisperm Antibodies in Infertile Men (1994) (124)
- Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). (2009) (123)
- Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]. (2011) (121)
- Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. (2004) (120)
- The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. (2001) (113)
- Ibandronate in the treatment of prostate cancer associated painful osseous metastases (2002) (111)
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. (2019) (110)
- Managing Nonmetastatic Castration-resistant Prostate Cancer. (2019) (106)
- Role of Wnt-5a in the Determination of Human Mesenchymal Stem Cells into Preadipocytes* (2009) (103)
- Somatic mutations of KIT in familial testicular germ cell tumours (2004) (98)
- Contemporary management of postchemotherapy testis cancer. (2012) (97)
- Surgical management of vesicoureteral reflux in pediatric patients (2004) (96)
- Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. (2008) (93)
- Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. (2019) (93)
- Management of chronic testalgia by microsurgical testicular denervation. (2002) (93)
- Organ preserving surgery in testicular epidermoid cysts. (1995) (90)
- Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme. (2014) (86)
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. (2019) (85)
- Risk factors for acute and chronic postoperative pain in patients with benign and malignant renal disease after nephrectomy (2009) (85)
- Preoperative pain as a risk factor for chronic post‐surgical pain – Six month follow‐up after radical prostatectomy (2009) (83)
- Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme. (2013) (82)
- Bilateral fine-needle administered local anaesthetic nerve block for pain control during TRUS-guided multi-core prostate biopsy: a prospective randomised trial. (2002) (82)
- Nephron-sparing surgery for renal angiomyolipoma. (2002) (81)
- Guidelines EAU Guidelines on Prostate Cancer (2007) (75)
- Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group. (2012) (75)
- A conservative approach to bilateral testicular germ cell tumors. (1995) (75)
- Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study. (2014) (73)
- Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05) (2014) (73)
- Testis-preserving surgery in bilateral testicular germ cell tumours. (1997) (70)
- Repeat retroperitoneal lymphadenectomy in advanced testicular cancer. (2005) (68)
- The role of retroperitoneal lymphadenectomy in mature teratoma of the testis. (1997) (67)
- Microsurgical Vasovasostomy versus Microsurgical Epididymal Sperm Aspiration/Testicular Extraction of Sperm Combined with Intracytoplasmic Sperm Injection (2000) (67)
- The human urothelium consists of multiple clonal units, each maintained by a stem cell (2011) (66)
- Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound (2017) (66)
- Quality-of-life issues in the treatment of testicular cancer (1999) (63)
- Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis (2001) (63)
- Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. (2011) (62)
- Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. (2020) (62)
- Transcutaneous penile oxygen pressure during bicycling (1999) (59)
- Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review. (2019) (59)
- Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. (2003) (58)
- Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium (2021) (58)
- Clonal architecture of human prostatic epithelium in benign and malignant conditions (2011) (58)
- Randomized phase III trial of 2 nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer : short-term versus prolonged treatment (2011) (56)
- Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. (2011) (56)
- 897 High-dose ibandronate is effective and well tolerated in the treatment of pain and hypercalcaemia due to metastatic urologic cancer (2003) (55)
- Ultrasound in the evaluation of urethral stricture disease: a prospective study in 175 patients. (1994) (55)
- Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer (2019) (55)
- Current Status of Cytotoxic Chemotherapy in Hormone Refractory Prostate Cancer (2001) (53)
- Current approaches to incorporation of radium-223 in clinical practice (2018) (52)
- Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinoma (2004) (50)
- Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary. (2018) (50)
- Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl‐2 oncogene in primary testicular germ cell tumours (1998) (50)
- Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours (2016) (50)
- Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium (2021) (49)
- Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice (2012) (49)
- Prevalence, severity, and chronicity of pain and general health‐related quality of life in patients with localized prostate cancer (2008) (48)
- Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases. (2018) (48)
- Results of Use of Tissue-Engineered Autologous Oral Mucosa Graft for Urethral Reconstruction: A Multicenter, Prospective, Observational Trial (2017) (48)
- Percentage of positive biopsies predicts lymph node involvement in men with low‐risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy (2008) (48)
- The influence of ejaculation on serum levels of prostate specific antigen. (1997) (47)
- The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer (2016) (47)
- Analysis of drug-related problems in three departments of a German University hospital (2016) (46)
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer. (2013) (46)
- The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. (2010) (46)
- [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. (2011) (45)
- Castration-resistant prostate cancer: where we stand in 2013 and what urologists should know. (2013) (45)
- Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer. (2010) (45)
- Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS (2015) (45)
- Testosterone measurement in patients with prostate cancer. (2010) (44)
- Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. (2003) (44)
- Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection (2019) (43)
- Substantial utilization of Facebook, Twitter, YouTube, and Instagram in the prostate cancer community (2018) (41)
- Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey (2020) (41)
- Anterior Urethroplasty Using a New Tissue Engineered Oral Mucosa Graft: Surgical Techniques and Outcomes (2018) (41)
- Epigenetic inactivation of ST6GAL1 in human bladder cancer (2014) (40)
- Testis Sparing Surgery for Benign Testicular Masses: Diagnostics and Therapeutic Approaches (2018) (39)
- Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors (2008) (39)
- Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer (2015) (39)
- Results and 10-Year Follow-Up in Patients with Squamous Cell Carcinoma of the Penis (1999) (38)
- Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel (2006) (38)
- Imaging Studies in Metastatic Urogenital Cancer Patients Undergoing Systemic Therapy: Recommendations of a Multidisciplinary Consensus Meeting of the Association of Urological Oncology of the German Cancer Society (2010) (37)
- SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer (2019) (37)
- Dendritic Cell-Based Immunotherapy of Renal Cell Carcinoma (1998) (37)
- Cytoreductive radical prostatectomy in patients with prostate cancer and low-volume skeletal metastases: Results of a feasibility and case-control study. (2015) (37)
- Experimental studies and first clinical experience with a new Lithoclast and ultrasound combination for lithotripsy. (2002) (37)
- cfDNA as a Prognostic Marker of Response to Taxane Based Chemotherapy in Patients with Prostate Cancer. (2015) (37)
- Preoperative erectile function is one predictor for post prostatectomy incontinence (2007) (37)
- A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy. (2014) (36)
- Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours. (2014) (36)
- MANAGEMENT OF BILATERAL TESTICULAR GERM CELL TUMOURS – EXPERIENCE OF THE GERMAN TESTICULAR CANCER STUDY GROUP (GTCSG) (2006) (36)
- Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial (2018) (36)
- Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? (2002) (35)
- Penile cancer: organ‐sparing techniques (2014) (35)
- Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping (2004) (34)
- High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis (2002) (34)
- Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia. (2012) (33)
- Pneumatic v electrokinetic lithotripsy in treatment of ureteral stones. (1998) (33)
- Local recurrence of an oncocytic adrenocortical carcinoma with ovary metastasis. (2001) (33)
- Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. (2008) (32)
- [Treatment outcomes in primary and secondary retroperitoneal fibrosis]. (2000) (32)
- Identification of high-risk prostate cancer: role of prostate-specific antigen, PSA doubling time, and PSA velocity. (2008) (32)
- Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy (2010) (31)
- Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program (2019) (31)
- Impact of Comorbidities on Post-Prostatectomy Incontinence (2006) (31)
- [The familial undescended testis]. (2003) (31)
- Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis. (2021) (31)
- Burden or relief: do second-opinion centers influence the quality of care delivered to patients with testicular germ cell cancer? (2010) (31)
- Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality (2017) (30)
- [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy]. (2006) (30)
- Nephrogenic Adenoma:A Rare Bladder Tumor in Children (1999) (29)
- MOLECULAR ANALYSIS OF P16Ink4/CDKN2 AND P15Ink4B/MTS2 GENES IN PRIMARY HUMAN TESTICULAR GERM CELL TUMORS (1998) (29)
- Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results. (2015) (29)
- Contralateral testicular biopsy in testis cancer: current concepts and controversies (2009) (29)
- Paternity in patients with bilateral testicular germ cell tumors. (1997) (29)
- Salvage Local Treatments After Focal Therapy for Prostate Cancer. (2019) (29)
- German second-opinion network for testicular cancer: Sealing the leaky pipe between evidence and clinical practice (2014) (29)
- Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous‐Cell Carcinoma: Results of a Multicenter Analysis (2017) (29)
- Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial. (2017) (28)
- Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: Survival results from a prospective, randomized trial (LEA AUO AB 25/02). (2016) (28)
- Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients (2015) (27)
- Two‐ and three‐/four dimensional perineal ultrasonography in men with urinary incontinence after radical prostatectomy (2012) (27)
- Cellular fibronectin in patients with transitional cell carcinoma of the bladder (2003) (27)
- Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial. (2010) (26)
- Role of salvage lymph node dissection in prostate cancer (2016) (25)
- Isolated candidal prostatitis. (2000) (25)
- Synchronous bilateral testicular tumour: nonseminomatous germ cell tumours and contralateral benign tumours. (1997) (25)
- Giant hydronephrosis mimicking progressive malignancy (2003) (25)
- Organ‐preserving surgery for testicular tumours (2012) (25)
- Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program. (2019) (25)
- OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro (2014) (25)
- Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content (2016) (25)
- Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors. (1997) (25)
- Low-Dose Characterization of Kidney Stones Using Spectral Detector Computed Tomography: An Ex Vivo Study (2018) (24)
- Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study. (2019) (24)
- Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review (2010) (24)
- The role of palliative surgery in castration-resistant prostate cancer (2014) (24)
- Bisphosphonates in the Management of Metastatic Prostate Cancer (2003) (24)
- Second-line chemotherapy with docetaxel for prostate-specific antigen (PSA) relapse in men with hormone-refractory prostate cancer (HRPC) previously treated with docetaxel-based chemotherapy (2005) (23)
- One course of adjuvant PEB chemotherapy versus retroperitoneal lymph node dissection in patients with stage I non-seminomatous germ-cell tumors (NSGCT): Results of the German Prospective Multicenter Trial (Association of Urological Oncology [AUO]/German Testicular Cancer Study Group [GTCSG] Trial 01 (2006) (23)
- Preoperative chronic pain in radical prostatectomy patients: preliminary evidence for enhanced susceptibility to surgically induced pain (2010) (23)
- Plasma Levels of Cellular Fibronectin in Patients with Localized and Metastatic Renal Cell Carcinoma (2004) (23)
- Ibandronate in metastatic bone pain. (2004) (23)
- Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels (2018) (23)
- First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry. (2016) (22)
- Molecular Genetic Parameters in Pathogenesis and Prognosis of Testicular Germ Cell Tumors (2000) (22)
- TGF-β1 in patients with renal cell carcinoma (2002) (22)
- Weekly docetaxel plus estramustine for hormone-refractory prostate cancer (HRPC) with intermittent repetition: Preliminary results of a multicenter phase II study (AUO AP33/02) (2005) (22)
- Testicular tissue oxygen pressure. (1996) (22)
- Prognostic factors in low-stage nonseminomatous testicular cancer. (1996) (21)
- Giant Calculus of the Posterior Urethra following Recurrent Penile Urethral Stricture (2002) (21)
- The German S3 Guideline Prostate Cancer (2010) (21)
- Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis. (2020) (21)
- Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians. (2021) (21)
- Prognostic risk factors in low stage testicular germ cell tumors (1997) (20)
- Magnetic Resonance Urography in Pediatric Urology (2003) (20)
- Long‐Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3‐Year Open Label Followup Results (2018) (20)
- Impact of the COVID-19 Pandemic on Urologists in Germany (2020) (20)
- Clinical stage I nonseminomatous testicular germ-cell tumors: surgery or watchful waiting, still an issue? (2002) (20)
- European Association of Urology Guidelines on Testis Cancer: Important Take Home Messages. (2019) (19)
- Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder. (2013) (19)
- Next-generation sequencing reveals potential predictive biomarkers and targets of therapy for urothelial carcinoma in situ of the urinary bladder. (2019) (19)
- Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages (2021) (19)
- Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68 Ga-PSMA and 11 C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections (2020) (19)
- Surgical resection of urological tumor metastases following medical treatment. (2012) (19)
- Non–Guideline‐concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse‐free Survival (2017) (19)
- Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care. (2012) (19)
- Microscopic and biochemical fertility characteristics of semen after shockwave lithotripsy of distal ureteral calculi. (2001) (18)
- The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2015) (18)
- Low-dose rate brachytherapy for men with localized prostate cancer. (2011) (18)
- Impact of evidence‐based interdisciplinary guidelines on testis cancer management (2006) (18)
- Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer (2019) (18)
- Beyond the 3′UTR binding–microRNA-induced protein truncation via DNA binding (2018) (18)
- Aneuploidy of Chromosome 9 and the Tumor Suppressor Genes p16INK4 and p15INK4B Detected by in situ Hybridization in Locally Advanced Prostate Cancer (2000) (18)
- [Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]. (2000) (18)
- Robot-Assisted Radical Prostatectomy for the Treatment of Radiation-Resistant Prostate Cancer: Surgical, Oncological and Short-Term Functional Outcomes (2013) (18)
- Combining Lithoclast and ultrasound power in one device for percutaneous nephrolithotomy: in vitro results of a novel and highly effective technology. (2003) (18)
- Sacral Colpopexy with Concurrent Burch Colposuspension in Patients with Vaginal Vault Prolapse (2006) (18)
- Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. (2020) (17)
- [The lymph node staging of malignant testicular germ-cell tumors]. (1999) (17)
- Predicting Response and Recognizing Resistance: Improving Outcomes in Patients With Castration-resistant Prostate Cancer. (2017) (17)
- [European Association of Urology guidelines on urinary and male genital tract infections]. (2003) (17)
- Predictors of thrombosis in testicular cancer during platinum-based chemotherapy (2018) (17)
- Eliminating the need of serum testing using low serum culture conditions for human bone marrow-derived mesenchymal stromal cell expansion (2013) (17)
- Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer (2017) (17)
- Randomized phase III trial of 2nd line gemcitabine/paclitaxel chemotherapy in patients with advanced bladder cancer: Temporary versus maintenance treatment (German Association of Urologic Oncology (AUO) Trial AB 20/99) (2008) (16)
- An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application (2020) (16)
- Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study. (2015) (16)
- Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma. (2020) (16)
- Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer (2019) (16)
- Interpreting the Clinical Significance of Quality of Life Score Changes after Radiotherapy for Localized Prostate Cancer (2011) (16)
- Dose independent characterization of renal stones by means of dual energy computed tomography and machine learning: an ex-vivo study (2019) (16)
- Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer (2018) (16)
- The Role of Palliative Surgery in Castration-Resistant Prostate Cancer (2015) (16)
- Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma. (2019) (16)
- Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue. (2011) (16)
- [Radical salvage prostatectomy : Treatment of local recurrence of prostate cancer after radiotherapy]. (2008) (16)
- Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. (1998) (15)
- Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information? (2017) (15)
- Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease (2004) (15)
- Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours. (2002) (15)
- Pyruvate Kinase Type Tumor M2 in Urological Malignancies (2003) (15)
- Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease. (2019) (15)
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer. (2013) (15)
- Cryoablation of Localized Prostate Cancer (1998) (14)
- Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection (2020) (14)
- 1149PResults of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC) (2017) (14)
- Application of mesenchymal stromal cells in urological diseases (2010) (14)
- MRI-guided transurethral ultrasound ablation of prostate cancer. (2020) (14)
- Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC). (2013) (14)
- Radical retropubic and perineal prostatectomy for clinically localised prostate cancer in renal transplant recipients (2014) (14)
- [Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors]. (2012) (14)
- Residual tumour resection following inductive chemotherapy in advanced testicular cancer. (2007) (14)
- Radical prostatectomy in 2007: oncologic control and preservation of functional integrity. (2008) (14)
- A multicenter paper-based and web-based system for collecting patient-reported outcome measures in patients undergoing local treatment for prostate cancer: first experiences (2020) (13)
- Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node‐positive penile squamous cell carcinoma (2020) (13)
- Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology. (2003) (13)
- Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker? (2002) (13)
- No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients (2012) (13)
- Is there an anti-androgen withdrawal syndrome for enzalutamide? (2014) (13)
- Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results. (1998) (13)
- [Guidelines for German urologists on diagnosis of benign prostate syndrome]. (2003) (13)
- Open versus Laparoscopic Radical Cystectomy (2006) (13)
- Websites on Bladder Cancer: an Appropriate Source of Patient Information? (2019) (13)
- Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. (2021) (13)
- The Treatment of Hormone Refractory Prostate Cancer (2003) (13)
- Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D). (2014) (13)
- Posttraumatic High-Flow Priapism in a 10-Year-Old Boy: Superselective Embolization of the Arteriovenous Fistula (1998) (12)
- Diagnosis and management of the growing teratoma syndrome: A single-center experience and review of the literature. (2018) (12)
- Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial (2018) (12)
- MicroRNAs as Urinary Biomarker for Oncocytoma (2018) (12)
- A risk calculator predicting recurrence in lymph node metastatic penile cancer (2020) (12)
- MICROWAVE THERMOTHERAPY FOR BENIGN PROSTATIC HYPERPLASIA WITH THE DORNIER UROWAVE (1999) (12)
- TGF-beta1 in patients with renal cell carcinoma. (2002) (12)
- 1031 PATHOHISTOLOGICAL FINDINGS IN PATIENTS WITH NONSEMINOMATOUS GERM CELL TUMOURS (NSGCT) WHO UNDERGO POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) FOR SMALL TUMOURS (2011) (12)
- SECOND-LINE CHEMOTHERAPY WITH DOCETAXEL FOR PROSTATESPECIFIC ANTIGEN (PSA) RELAPSE IN MEN WITH HORMONEREFRACTORY PROSTATE CANCER (HRPC) PREVIOUSLY TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY (2006) (12)
- Investigations on bone metabolism of urological tumors forming metastases. (1996) (12)
- Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy (2020) (11)
- Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates (2012) (11)
- Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial. (2006) (11)
- Health‐related quality of life in active surveillance and radical prostatectomy for low‐risk prostate cancer: a prospective observational study (HAROW ‐ Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting) (2018) (11)
- Comparison of second-line treatments in patients with castration-resistant prostate cancer with PSA relapse after or during docetaxel chemotherapy. (2012) (11)
- Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial. (2014) (11)
- Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome (2016) (11)
- Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation. (2013) (11)
- 68Ga‐PSMA‐PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer (2020) (11)
- Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries (2018) (11)
- How to Perform Image-guided Prostate Biopsy: In-bore and Fusion Approaches. (2016) (11)
- Microstructure and cytocompatibility of collagen matrices for urological tissue engineering (2011) (10)
- ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC). (2018) (10)
- Renal milk of calcium: contraindication to extracorporeal shockwave lithotripsy. (1996) (10)
- Nuclear medical assessment of penile hemodynamics following revascularization surgery. (1997) (10)
- Anatomical Extent of Pelvic Lymphadenectomy in Bladder and Prostate Cancer (2005) (10)
- Comprehensive analysis of metastatic seminoma germ cell tumors shows divergent expression of immune-related pathways. (2019) (10)
- [Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]. (2018) (10)
- New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer (2017) (10)
- Painless ESWL by cutaneous application of vaseline. (1995) (10)
- Radiotherapy and Hormone Treatment in Prostate Cancer. (2016) (10)
- Size and volume of kidney stones in computed tomography: Influence of acquisition techniques and image reconstruction parameters. (2020) (10)
- Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer? (2017) (10)
- Improving the efficacy of targeted trials by multiple-marker analysis in castration-resistant prostate cancer. (2011) (10)
- Comparison of adjustable male slings and artificial urinary sphincter in the treatment of male urinary incontinence: a retrospective analysis of patient selection and postoperative continence status (2018) (10)
- 106 Cabazitaxel adverse events are manageable in senior adults with metastatic castration-resistant prostate cancer (mCRPC): Results of the European Compassionate Use Programme (2013) (10)
- [Androgen deprivation for advanced prostate cancer]. (2008) (10)
- [Pelvic lymphadenectomy and radical prostatectomy. Recommendations of the German S3 guideline]. (2010) (10)
- Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. (2020) (10)
- Lutetium-177-PSMA-Radioligandentherapie (2018) (9)
- [Guidelines of German urologists on therapy of benign prostate syndrome]. (2003) (9)
- TERRAIN: A randomized, double-blind, phase II study comparing MDV3100 with bicalutamide (Bic) in men with metastatic castrate-resistant prostate cancer (CRPC). (2012) (9)
- 413 Permanent interstitial low-dose rate brachytherapy for patients with localized prostate cancer – a systematic review of randomized and non-randomized controlled clinical trials (2012) (9)
- Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. (2019) (9)
- Tolerability of Cabazitaxel in Senior Adults with Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Europe (2012) (9)
- Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)) (2019) (9)
- PARTIN TABLES DO NOT ADEQUATELY PREDICT THE RISK OF LYMPH NODE INVOLVEMENT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY Localised PROSTATE CANCER (2006) (9)
- Guidelines and counselling for treatment options in the management of prostate cancer. (2007) (9)
- Testicular Cancer on the Web—an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines? (2018) (9)
- Pathohistologic findings in patients with nonseminomatous germ cell tumors (NSGCT) who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumors. (2011) (9)
- Palliative Radical (Cysto-)prostatectomy for Locally Advanced, Symptomatic Castration-resistant Prostate Cancer. (2016) (9)
- [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours]. (2016) (9)
- 632 Surgical considerations in residual tumour resection following chemotherapy for advanced testicular cancer (2004) (9)
- The current landscape of salvage therapies for patients with bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer (2021) (9)
- [Treatment options for hormone-refractory prostate cancer]. (2005) (9)
- PROSPER: A phase 3 study of enzalutamide in nonmetastatic (M0) castration-resistant prostate cancer (CRPC) patients. (2014) (9)
- Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients. (2008) (9)
- The Role of Anatomic Extented Pelvic Lymphadenectomy in Men Undergoing Radical Prostatectomy for Prostate Cancer (2005) (8)
- Application of retinoids in the treatment of renal cell carcinoma—a futile effort? (2004) (8)
- [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]. (2005) (8)
- In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance (2015) (8)
- Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme (2019) (8)
- COMPLICATIONS OF POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED TESTIS CANCER (2009) (8)
- 825 11C-COLINE-POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY (C-PET/CT) FOR TUMOR LOCALIZATION OF LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPY (2007) (8)
- Clinical impact of MDR1-expression in testicular germ cell cancer. (2007) (8)
- Anatomic Extent of Pelvic Lymphadenectomy in Bladder Cancer (2010) (8)
- Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia in situ. (2020) (8)
- New Developments in the Management of Prostate Cancer (2015) (8)
- Prostate cancer: Treatment sequencing for CRPC—what do we know? (2014) (8)
- Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma (2005) (8)
- Basic science and research in renal cell carcinoma: from workbench to bedside (2003) (8)
- Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines (2011) (8)
- [Testicular epidermoid cyst: orchiectomy or enucleation resection?]. (1996) (8)
- Population-based investigation of familial undescended testis and its association with other urogenital anomalies. (2005) (8)
- 306 DOCETAXEL (DOC) AND MITOXANTRON (MIT) IN THE MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER (HRPCA) (2007) (8)
- The pioneer and differentiation factor FOXA2 is a key driver of yolk‐sac tumour formation and a new biomarker for paediatric and adult yolk‐sac tumours (2021) (7)
- Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study. (2021) (7)
- [Reduced morbidity in resection of residual tumors after chemotherapy for seminoma]. (2015) (7)
- [Palliative radical (cysto)prostatectomy in locally advanced castration-resistant prostate cancer]. (2011) (7)
- [Residents training in private practice : Conflicts between circumstances, willingness, and reality]. (2016) (7)
- Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. (2018) (7)
- Minimally invasive treatment for localized prostate cancer. (2012) (7)
- [Robot-assisted radical prostatectomy in elderly patients: surgical, oncological and functional outcomes]. (2012) (7)
- Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer. (2013) (7)
- Isolierte Nebenhodentorsion bei Hoden-Nebenhoden-Dissoziation (2001) (7)
- Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen (2016) (7)
- External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancer. (2019) (7)
- Evaluation of the inferior vena cava (IVC) by magnetic resonance imaging in advanced testicular germ cell tumors (1998) (7)
- Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy (2021) (7)
- 2561 Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (EAP) (2015) (7)
- Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study (2021) (7)
- Molecular Serological Detection of DNA Alterations in Transitional Cell Carcinoma Is Highly Sensitive and Stage Independent (2004) (7)
- Radium-223 (Ra-223) therapy after abiraterone (Abi): Analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). (2018) (7)
- Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy. (2012) (7)
- [Microsurgical vasovasostomy in the age of modern reproduction medicine. A cost-benefit analysis]. (2000) (7)
- Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study (2020) (7)
- [Compartment syndrome: a complication of lithotomy position]. (1996) (7)
- External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma (2018) (7)
- Urothelial or oral mucosa cells for tissue-engineered urethroplasty: A critical revision of the clinical outcome (2019) (7)
- Diffuse Metastasized Testicular Teratoma and Paraneoplastic Thyreotoxicosis (2000) (7)
- Giant Retroperitoneal Hemangiopericytoma with Paraneoplastic Gynecomastia (1999) (7)
- [Surgical treatment of pelvic organ prolapse]. (2018) (7)
- [Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy]. (1999) (7)
- Intermittent vs continuous docetaxel therapy in patients with metastatic castration‐resistant prostate cancer – a phase III study (PRINCE) (2018) (7)
- [Interdisciplinary education in urology: innovations for better training]. (2019) (7)
- [Thoracoabdominal resection of retrocrural residual tumors]. (2004) (7)
- [Isolated epididymal torsion in dissociation of testis-epididymis]. (2002) (7)
- [Lethal course after chemotherapy with docetaxel. Acute liver failure with accompanying erythema multiforme major]. (2007) (6)
- Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors. (2020) (6)
- [18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer (2020) (6)
- Transurethral Needle Ablation of the Prostate: An Alternative Minimally Invasive Therapeutic Concept in the Treatment of Benign Prostate Hyperplasia (1998) (6)
- PRINCE: A phase III study comparing intermittent docetaxel therapy versus continuous docetaxel therapy in patients with castration-resistant prostate cancer. (2016) (6)
- 1000: Post-Chemotherapy Retroperitoneal Resection of Residual Masses in Germ Cell Cancer with Modified Template Resection (2007) (6)
- Manual kidney stone size measurements in computed tomography are most accurate using multiplanar image reformatations and bone window settings (2021) (6)
- Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3). (2020) (6)
- Cabazitaxel (CBZ) + Prednisone (P; CBZP) in Patients (PTS) with Metastatic Castration-Resistant Prostate Cancer (MCRPC) Previously Treated with Docetaxel (D): Interim Results from Compassionate-Use Programme (CUP) and Early-Access Programme (EAP) (2012) (6)
- Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 2 (2021) (6)
- [Value of urethral ultrasound in evaluation of pathologic urethral changes]. (2008) (6)
- [Multimodal therapy of locally advanced prostate cancer]. (2016) (6)
- 747 Prospective randomized multicenter study comparing limited vs extended pelvic lymphadenectomy in intermediate and high risk prostate cancer – first descriptive results (SEAL, AUO AP 55/09) (2014) (6)
- Patterns of Recurrence Following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies. (2021) (6)
- Renal function following xenon anesthesia for partial nephrectomy—An explorative analysis of a randomized controlled study (2017) (6)
- [Organ saving therapy of bilateral testicular tumor]. (1993) (6)
- Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™ (2015) (6)
- The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens (2021) (6)
- Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer. (2020) (6)
- Modern surgical strategies in the management of complex ureteral strictures. (2021) (6)
- [The role of tumour markers in diagnosis and management of testicular germ cell tumours]. (2011) (6)
- Management of residual masses in testicular germ cell tumors (2019) (6)
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC). (2019) (6)
- [Palliative subcutaneous urinary diversion in malignant ureteral obstruction (detour system)]. (2004) (5)
- [Pulmonary metastasectomy in renal cell carcinoma]. (2017) (5)
- [Hemangioma of the glans penis. Its therapy by neodymium:YAG laser]. (1992) (5)
- Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration. (2020) (5)
- [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor]. (2004) (5)
- 588: Prediction of Residual Retroperitoneal Mass Histology following Postchemotherapy Retroperitoneal Surgery for Metastatic Nonseminomatous Germ Cell Tumors: Role of MDR-1 and Mismatch Repair Genes (2007) (5)
- Diffuse metastasized testicular teratoma and paraneoplastic thyreotoxicosis. Case report and literature review. (1999) (5)
- [Organ-preserving renal tumor surgery for renal cell carcinoma ≥T1b: operative technique, complications and oncological control]. (2012) (5)
- Ketokonazol/hydrocortisone versus estramustinphosphate in the management of PSA progression following primary androgen deprivation for metastatic prostate cancer (2005) (5)
- Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra. (2012) (5)
- The upregulation of hypoxia-related miRNA 210 in primary tumor of lymphogenic metastatic prostate cancer. (2018) (5)
- Predictive value of the UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classification for patients treated with radical prostatectomy. (2018) (5)
- Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy (2012) (5)
- Ibandronate in metastatic bone pain : Ibandronate (2004) (5)
- [Quality of life of patients with prostate cancer under androgen deprivation with GnRH analogues: Results of the noninterventional study TRIPTOSIX]. (2016) (5)
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase III trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC). (2019) (5)
- Quality control in radical (laparoscopic) prostatectomy. (2006) (5)
- Intraoperative frozen section analysis to monitor nerve-sparing radical prostatectomy. (2006) (5)
- Rectal morbidity after permanent interstitial brachytherapy for prostate cancer--impact of day 1 vs. day 30 computed tomography-based postimplant dosimetry. (2010) (5)
- 302 EAU GUIDELINE ON CLINICALLY LOCALIZED PROSTATE CANCER: COMPLIANCE AMONG UROLOGISTS CONCERNING DIAGNOSIS, STAGING AND TREATMENT (2011) (5)
- 859PAnti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels (2017) (5)
- 1093 EAU GUIDELINE ON ADVANCED PROSTATE CANCER: COMPLIANCE AMONG UROLOGISTS CONCERNING ANDROGEN DEPRIVATION THERAPY (2011) (5)
- Current Approach to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer (2010) (5)
- [Reconstructive urethral surgery]. (2017) (5)
- Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours (2022) (5)
- A continent urinary diversion in a female with agenesis of the bladder: a 5-year follow-up. (2012) (5)
- The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy (2020) (5)
- Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection - A 13-year follow-up analysis of a phase III trial cohort. (2021) (5)
- Giant retroperitoneal hemangiopericytoma with paraneoplastic gynecomastia. Case report and literature review. (1999) (5)
- [Therapy of hormone-refractory prostate cancer]. (2005) (5)
- Sex-dependent urolithiasis in the portacaval shunt rat. 2. Hormones and stone formation. (1993) (5)
- Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging (2021) (5)
- Highlights on Prostate Cancer from Urological and Oncological Congresses in 2007. (2008) (5)
- 270 Prospective randomized multicenter study comparing limited vs extended pelvic lymphadenectomy in intermediate and high risk prostate cancer – comparison of complications (SEAL, AUO AP 55/09) (2014) (5)
- Effect of a Single Bout of Aerobic Exercise on Kynurenine Pathway Metabolites and Inflammatory Markers in Prostate Cancer Patients—A Pilot Randomized Controlled Trial (2020) (5)
- Sex-dependent urolithiasis in the portacaval shunt rat. Part I. (1993) (5)
- MOLECULAR TRIGGERED THERAPY IN HORMONE-REFRACTORY PROSTATE CANCER (2006) (5)
- Inguinal Fibrolipoma of the Spermatic Cord: Discrepancies between Clinical and Histopathological Findings (2003) (5)
- Metastatic surgery in testis cancer (2016) (5)
- Pelvic exenteration surgery in patients with locally advanced castration‐naïve and castration‐resistant, symptomatic prostate cancer (2020) (5)
- Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymphadenectomy: optimizing a risk-adapted surgical approach. (2012) (5)
- Managing metastatic bone disease: three case studies. (2004) (5)
- Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response (2021) (5)
- The current role of precision surgery in oligometastatic prostate cancer (2022) (4)
- Prostate cancer: Estimated life expectancy: integration of age and comorbidities (2016) (4)
- [Possibilities for surgical correction of an anastomotic stricture after radical prostatectomy]. (2011) (4)
- [Change of the LHRH analogue in progressive castration-refractory prostate cancer]. (2012) (4)
- LBA20 MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) IN PATIENTS WITH LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS OF TACT PIVOTAL STUDY (2018) (4)
- The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3) (2021) (4)
- Antiangiogenic therapies in urogenital malignancies (2017) (4)
- ACUTE RETINAL SIDE EFFECTS OF A SINGLE DOSE OF 100 mg SILDENAFIL (1999) (4)
- Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial (2018) (4)
- 634 Repeat retroperitoneal lymph node dissection for advanced testicular cancer — an avoidable complication? (2004) (4)
- A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results. (2012) (4)
- Comparison of second-line treatments in patients with castration-resistant prostate cancer with PSA relapse after or during docetaxel chemotherapy. (2012) (4)
- 1039 PROGNOSTIC RISK FACTORS TO PREDICT FINAL PATHOHISTOLOGY IN PATIENTS UNDERGOING RADICAL SALVAGE PROSTATECTOMY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPY (2007) (4)
- [Stage-specific treatment for testicular germ cell tumours]. (2009) (4)
- Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy. (2012) (4)
- Post-chemotherapy retroperitoneal resection of residual masses in germ cell cancer with modified template resection (2008) (4)
- Late toxicities and recurrences in patients with clinical stage I nonseminomatous germ cell tumor after one cycle of adjuvant BEP versus primary retroperitoneal lymph node dissection: A 13-years follow-up analysis of a phase III trial cohort. (2020) (4)
- [Perception of the COVID-19 Pandemic among Pneumology Professionals in Germany]. (2020) (4)
- Salvage management of patients with relapsing testicular germ cell tumors (2021) (4)
- Corrigendum to: "European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer (2008) (4)
- Multidisciplinary Team Meetings for Prostate Cancer Treatment: We Can Do Much Better in Daily Life (2019) (4)
- Prognostic impact of LDH and HCG levels in marker-positive seminomas. (2020) (4)
- 899 DOCETAXEL RECHALLENGE VERSUS DOCETAXEL/BEVACIZUMAB IN CASTRATION-RESISTANT PROSTATE CANCER FOLLOWING FIRST LINE DOCETAXEL (2010) (4)
- [Nerve sparing radical retropubic prostatectomy and lymph node excision in prostate carcinoma]. (2005) (4)
- Complications of primary nerve-sparing retroperitoneal lymphadenectomy in clinical stage I nonseminatous testis cancer (2002) (4)
- Improving Flexibility and Quality of Life for Your Patients: A Must? (2009) (4)
- Fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide: data from randomised clinical trials (2016) (4)
- Bisphosphonates for advanced prostate cancer. (2017) (4)
- Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP) (2017) (4)
- What is New in Bladder Cancer Diagnosis and Management (2008) (4)
- [Importance of pathology for therapy planning of testicular germ cell tumors]. (2014) (4)
- [Intestinal neobladder fistula after radical cystectomy and orthotopic ileal neobladder]. (2011) (4)
- Adverse events of special interest assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials. (2019) (4)
- [Complete resection of urothelial cancer metastases with curative intent]. (2009) (4)
- Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients. (2014) (3)
- Bilateral germ cell cancer of the testis: a report of 11 patients with a long‐term follow‐up (2001) (3)
- Docetaxel versus docetaxel plus bevacizumab in progressive castration-resistant prostate cancer following first-line docetaxel. (2010) (3)
- A multicenter phase I study of DI17E6, a novel de-immunized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer (CRPC) with bone metastases after chemotherapy. (2011) (3)
- [When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?] (2017) (3)
- Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Part 1 (2021) (3)
- Choline‐positron emission tomography/CT in patients with relapsing prostate cancer: to be performed with therapeutic consequences only (2015) (3)
- PII-LBA4 TERRAIN TRIAL: PROSTATE-SPECIFIC ANTIGEN KINETICS AND QUALITY OF LIFE RESULTS OF ENZALUTAMIDE VERSUS BICALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2015) (3)
- Temozolomide in the management of progressive metastatic renal cell cancer (RCC) following immunotherapy (2005) (3)
- [Clinical network structures in uro-oncology. A model for the future?]. (2008) (3)
- A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part (2014) (3)
- Evaluation of the oncologic benefit of adjunctive surgery at time of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). (2020) (3)
- Diagnosis of penile hemangioma by use of biopty gun for corpus cavernosum biopsy. (1995) (3)
- Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a Cochrane Review and network meta‐analysis (2018) (3)
- Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma. (2021) (3)
- Comparative Analysis of Elderly Patients Undergoing Radical Cystectomy With Ureterocutaneostomy or Ileal Conduit With a Special Focus on Bowl Complications Requiring Surgical Revision (2022) (3)
- [Documentation of the Governing Body of Prostate Centers (DVPZ)]. (2013) (3)
- A novel 18 F ‐ labeled PSMA ligand for PET/CT imaging of prostate cancer patients: First ‐ in ‐ man observational study and clinical experience with 18 F ‐ JK ‐ PSMA ‐ 7 during the first year of application (2019) (3)
- 649 Do evidence based guidelines influence the indivisual therapeutic approach in patients with testicular cancer (2004) (3)
- Pelvic lymphadenectomy in clinically localised prostate cancer: counting lymph nodes or dissecting primary landing zones of the prostate? (2014) (3)
- Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review (2021) (3)
- Prognostic clinical parameters to predict the necessity of reconstructive vascular surgery for patients who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for advanced nonseminatous germ cell tumors (NSGCT). (2011) (3)
- Salvage radical prostatectomy. (2005) (3)
- Genitourinary tumors, prostate (2012) (3)
- LBA-26 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER (2019) (3)
- Nerve sparing retroperitoneal lymph node dissection in clinical stage IIA/B seminoma: The COTRIMS trial. (2022) (3)
- Amifostine as protective agent in cisplatin-based chemotherapy of advanced bladder cancer (1999) (3)
- MANAGEMENT ANALYSIS OF PATIENTS WHO DIED OF GERM CELL TUMORS (1999) (3)
- Lymph Node Assessment in Prostate Cancer: Evaluation of Iodine Quantification With Spectral Detector CT in Correlation to PSMA PET/CT. (2021) (3)
- Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study (2022) (3)
- A rare case of tined lead migration of InterStim device into the rectum with subsequent novel combined surgical-endoscopic removal technique. (2020) (3)
- [Treatment mapping of prostate cancer in DVPZ prostate centers in Germany]. (2015) (3)
- PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy (2011) (3)
- Phase 1b study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTEimmune-oncology therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate cancer (NEPC). (2021) (3)
- Gastroparesis after retroperitoneal surgery successfully treated with erythromycin. (2000) (3)
- Long-term therapy with sunitinib and sorafenib in patients with metastasizing renal cell carcinoma. (2011) (3)
- Management of advanced prostate cancer: gonadotropin-releasing hormone blockers might improve prognosis. (2008) (3)
- Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer (2021) (3)
- Alpha-Fetoprotein-Producing Gastric Cancer Mimicking Extragonadal Testicular Cancer (2001) (3)
- Functional outcome and quality of life in patients undergoing salvage radical prostatectomy (SRPE). (2018) (3)
- Perioperative Outcomes of Transurethral Resection, Open Prostatectomy, and Laser Therapy in the Surgical Treatment of Benign Prostatic Obstruction: A “Real-World” Data Analysis from the URO-Cert Prostate Centers (2021) (3)
- Safety and mid‐term surgical results of anterior urethroplasty with the tissue‐engineered oral mucosa graft MukoCell®: A single‐center experience (2021) (3)
- [Ablatio testis and enucleation resection]. (2009) (3)
- Sex-Dependent Urolithiasis in The Portocaval Shunt Rat (1993) (3)
- CLINICAL T3 PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: RESULTS FROM THE EUROPEAN SOCIETY OF ONCOLOGICAL UROLOGY (ESOU) (2008) (3)
- Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy - Experience at a tertiary referral center. (2022) (3)
- RANDOMISED PHASE III TRIAL COMPARING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) WITH ONE COURSE OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH STAGE I NON-SEMINOMATOUS GERM CELL TUMOUR PATIENTS (NSGCT) – UPDATED RESULTS OF AUO TRIAL 01/94 (2008) (3)
- Radium-223 (Ra-223) in asymptomatic metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP). (2017) (3)
- Distinct distribution patterns of exercise-induced natural killer cell mobilisation into the circulation and tumor tissue of patients with prostate cancer. (2022) (3)
- Accuracy of 68Ga-PSMA-PET/CT for patient selection for lymphadenectomy in addition to salvage radical prostatectomy in locally recurrent prostate cancer after primary radiotherapy. (2017) (2)
- Interdisciplinary Management of Testicular Germ Cell Tumors - More Needed than Ever! (2018) (2)
- Bilateral testicular tumors. Combination of a testicular germ cell tumor with a contralateral benign non-germ cell tumor (1999) (2)
- [Implementation of telemedicine in daily care of urological patients]. (2018) (2)
- Prediction of Radioresistant Prostate Cancer Based on Differentially Expressed Proteins (2020) (2)
- QUALITY CONTROL IN NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY – RESULTS OF THE EUROPEAN SOCIETY OF ONCOLOGICAL UROLOGY (ESOU) (2008) (2)
- Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Two-year follow-up (2020) (2)
- 802TiPPROSPER: A PHASE 3 STUDY OF ENZALUTAMIDE IN NON-METASTATIC (M0) CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS. (2014) (2)
- Novel therapies for advanced urologic cancers. (2020) (2)
- Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases after chemotherapy. (2012) (2)
- Advanced Prostate Cancer Consensus Conference 2017 (2018) (2)
- [Value of targeted therapy for penile cancer]. (2008) (2)
- Efficacy of the Oestrogen Antagonist Tamoxifen on Sperm Parameters in Patients with Idiopathic Oligoathenoteratozoospermia (2019) (2)
- What is the optimal post-operative management of men with lymph node recurrent prostate cancer after salvage lymph node dissection? Results from a large, multi-institutional series (2017) (2)
- VASOVASOSTOMY (VVS) VERSUS MESA/TESE COMBINED WITH ICSI - A COST BENEFIT ANALYSIS (1999) (2)
- Cytoreductive radical prostatectomy (cRP) is feasible in men with hormone-naive, metastatic prostate cancer (mPCA) (2017) (2)
- Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases. (2010) (2)
- Mid-term results of anterior urethroplasty with tissue-engineered oral mucosa graft MukoCell® (2020) (2)
- [Microsurgical testicular spermatic cord denervation as therapy of chronic testicular pain]. (2002) (2)
- Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review. (2022) (2)
- Prognostic risk factors to predict final pathohistology in patients undergoing radical salvage prostatectomy for locally recurrent prostate cancer after radiation therapy (2007) (2)
- Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. (2018) (2)
- Assessing the under-estimation of nodal tumour burden by 68Ga-PSMA and 11C-choline PET/CT scan in patients treated with salvage lymph node dissection for nodal recurrence of prostate cancer: A large multi-institutional analysis (2018) (2)
- Evaluation of (18F) FDG-PET-CT for preoperative lymph-node staging of bladder cancer. (2012) (2)
- 801 Palliative radical (cysto)prostatectomy in locally advanced castration-resistant prostate cancer (2013) (2)
- [Radical cancer surgery of renal cell and prostate carcinoma with hematogenous metastasis: benefits]. (2014) (2)
- Non‐invasive urine markers for the differentiation between RCCs and oncocytoma (2019) (2)
- Prediction of residual retroperitoneal mass histology following postchemotherapy retroperitoneal surgery for metastatic nonseminomatous germ cell tumors: Role of MDR-1 and mismatch repair genes (2007) (2)
- [A paradigm shift. Defensive strategies for the treatment of localized prostate cancer in the new S3 guideline]. (2010) (2)
- KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients (2021) (2)
- [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study]. (2015) (2)
- Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy. (2022) (2)
- [Urgency after successful treatment of prostate cancer. Prospective study on the influence of treatment modality, morbidity, and epidemiological factors on the quality of life]. (2011) (2)
- 167: Impact of Electrical Stimulation or Biofeedback on Quality of Life After Radical Prostatectomy: Results of a Prospective Randomized Trial (2004) (2)
- 21 Extended retropubic radical prostatectomy in clinically stage T3 prostate cancer (PCA) — Significant reduction of positive surgical margins in a case control study (2005) (2)
- Re: incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. (2006) (2)
- PD10-03 ASSESSING THE UNDER-ESTIMATION OF NODAL TUMOUR BURDEN BY 68GA-PSMA AND 11C-CHOLINE PET/CT SCAN IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: A LARGE MULTI-INSTITUTIONAL ANALYSIS (2018) (2)
- [Treatment of bladder cancer. Value of radical prostate-sparing cystectomy]. (2012) (2)
- Enhanced overexpression of hypoxia-related miRNA-210 in primary tumor of metastatic prostate cancer. (2016) (2)
- PD23-12 UTILIZATION OF FACEBOOK, TWITTER, YOUTUBE AND INSTAGRAM IN THE PROSTATE CANCER COMMUNITY (2017) (2)
- Mxi-2 Dependent Regulation of p53 in Prostate Cancer (2020) (2)
- 875 A prospectively randomized phase II trial of pegylated doxorubicin in hormone refractory prostate cancer (2003) (2)
- 976Salvage radical prostatectomy in locally recurrent prostate cancer following radiation therapy (2005) (2)
- Interim safety analysis of a compassionate-use program (CUP) and early-access program (EAP) providing cabazitaxel (Cbz) plus prednisone (P) to patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel. (2013) (2)
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC). (2022) (2)
- [Testicular germ cell cancer : interdependence between guidelines and a second-opinion system]. (2009) (2)
- 782PSAFETY OF CABAZITAXEL + PREDNISONE (CBZ + P) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (DOC): COHORT COMPASSIONATE-USE PROGRAMME (CUP). (2014) (2)
- Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment (2022) (2)
- [Reconstructive surgery of ureteral stricture disease]. (2017) (2)
- Extended pelvic lymphadenectomy in men undergoing radical prostatectomy - an update on > 300 cases (2004) (2)
- [Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I]. (2009) (2)
- Re: Pattern of Progression After Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences. (2016) (2)
- The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer (2021) (2)
- Salvage radical prostatectomy after local radiotherapy in prostate cancer (2021) (2)
- 54 Extended pelvic lymphadenectomy in men undergoing radical retro pubic prostatectomy (RRP) — an update on > 300 cases (2004) (2)
- [Neoadjuvant and adjuvant chemotherapy in patients with advanced penile cancer]. (2007) (2)
- Locally recurrent prostate cancer following radiation therapy: to cut or to freeze? (2013) (2)
- Vimentin 3 Allows Differentiation between Normozoospermia and Oligoasthenoteratozoospermia (2019) (2)
- [Surgical management of female stress urinary incontinence]. (2018) (2)
- Postchemotherapy Retroperitoneal Lymph Node Dissection (2015) (2)
- [Visual diagnosis while performing transurethral resection of bladder tumors: power or myth?]. (2014) (2)
- [TNM-Classification of localized prostate cancer : The clinical T-category does not correspond to the required demands]. (2016) (2)
- [Pro and contra -- vesicoureteral reflux in childhood -- endoscopic administration vs. open reconstruction]. (2004) (2)
- [Molecular pathogenesis and prognostic factors in testicular tumor]. (1998) (2)
- Predictive factors for additional vascular procedures in patients with germ cell tumors (GCT) and residual tumor resection (RTR): A multicenter analysis of the German Testicular Cancer Study Groups (GTCSG). (2011) (2)
- [Node-positive prostate cancer. Value of radical prostatectomy]. (2010) (2)
- Testis-sparing Surgery in Adult Patients with Germ Cell Tumors: Systematic Search of the Literature and Focused Review (2022) (2)
- Multimodality Treatment in Advanced Prostate Cancer (2004) (2)
- Independent validation of two models to predict necrosis/fibrosis in post chemotherapy residual retroperitoneal masses of patients with advanced testicular cancer (2019) (2)
- [Peritoneal carcinomatosis after robotic-assisted radical cystectomy]. (2011) (2)
- Targeted Therapy in Patients with Metastatic Male Germ Cell Tumors (2021) (2)
- Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis (2022) (2)
- Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group. (2014) (2)
- [Organ-limited prostate cancer with positive resection margins. Importance of adjuvant radiation therapy]. (2012) (2)
- Modern Management of Castration-resistant Prostate Cancer (2013) (2)
- Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. (2021) (2)
- 11C-choline versus 68Ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: Results from a large, multi-institutional salvage lymph node dissection series (2017) (2)
- Genetic pathways and new progression markers for prostate cancer defined by microsatellite allelotyping (2004) (2)
- Feasibility and Oncologic Outcome of Salvage Surgery in Isolated Seminal Vesicle Remnants after Radical Prostatectomy (2021) (2)
- Prognostic risk factors for survival following adjuvant chemotherapy for locally advanced urothelial bladder cancer. (2006) (2)
- Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancer. (2021) (2)
- Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma. (2019) (1)
- IDENTIFYING THE OPTIMAL CANDIDATE FOR SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI‐INSTITUTIONAL ANALYSIS: PD15‐09 (2017) (1)
- [Radical retroperitoneal nephrectomy]. (2004) (1)
- Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H (2020) (1)
- Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of (2022) (1)
- 1045 LYMPH NODE METASTASES IN INTERMEDIATE RISK SQUAMOUS CELL CARCINOMA OF THE PENIS (2007) (1)
- Pivotal study of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Preliminary results (2019) (1)
- [Comment to P. J. Olbert et al., page 164]. (2009) (1)
- [Educational research in urology : Innovations for improving training]. (2019) (1)
- Even ‘low‐dose’ cabazitaxel requires careful and meticulous patient selection (2018) (1)
- [Ureterolysis, intraperitonealization of the ureter and ureter-ileum interposition in Ormond disease]. (2012) (1)
- Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study (2022) (1)
- Health-related quality of life in patients with advanced prostate cancer undergoing treatment with TRIPTOrelin Pamoate SIX month formulation: Results of the non-interventional TRIPTOSIX study. (2015) (1)
- How Much Chemotherapy Is Required to Optimise Long-term Outcomes in Clinical Stage 2 Seminoma? (2023) (1)
- Molecular pathogenesis and molecular prognosis factors of the testicular tumor (1998) (1)
- Is histoscanning a valid tool to detect prostate cancer in repeat biopsy? (2012) (1)
- Feasibility and oncologic outcome of salvage surgery in isolated seminal vesical remnants after radical prostatectomy. (2020) (1)
- [Primary paraurethral malignant mixed tumor (carcinosarcoma) of the vagina. A case report]. (1998) (1)
- Frequency and prognostic significance of the PSA flare-up phenomenon in men with castration-resistant prostate cancer (CRPC) who undergo docetaxel-based chemotherapy. (2012) (1)
- Five years into the national second-opinion project of the German Testicular Cancer Group (GCTSG): Impact on guideline implementation and the quality of care for testicular cancer patients. (2012) (1)
- MP79-07 LYMPH NODE STAGING IN BIOCHEMOCAL RECURRENT PROSTATE CANCER: DOES THE TRACER MATTERF-18-FLUOROETHYLCHOLINE VERSUS GA-68-PSMA-HBED-CC PET/CT (2016) (1)
- Retroperitoneal Laparoscopic Nephrectomy (RLN) versus open retroperitoneal nephrectomy (NX): ideal indication for newcomers (2002) (1)
- 131: Continent Vesicostomy in the Management of Severe and Recurrent Anastomotic Strictures Following Radical Prostatectomy (2005) (1)
- Analysis of fertility in patients with stage 1 non-seminomatous germ-cell tumours (NSGCT). The German prospective multicenter trial (2003) (1)
- Review: EAU Guidelines on Prostate Cancer (2009) (1)
- Vimentin 3 Expression in Prostate Cancer Cells (2021) (1)
- [Bilateral testicular tumors. Contralateral benign lesions in germ cell tumors of the testis]. (1999) (1)
- [Evaluation of gene therapy in the treatment of urological tumors]. (1999) (1)
- UPPER URINARY TRACT DECOMPRESSION USING ILEAL URETER REPLACEMENT IN COMPARISON TO ENDOURETERAL THERMOEXPANDABLE STENT [MEMOKATH 051]: MP24‐05 (2017) (1)
- 238 2D AND 3D/4D PERINEAL ULTRASOUND: FIRST EXPERIENCES IN MEN WITH URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY (2010) (1)
- 7044 POSTER Cabazitaxel Plus Prednisone for Patients With Metastatic Castration-resistant Prostate Cancer Previously Treated With a Docetaxel-containing Regimen – Interim Analysis Results From an Ongoing Compassionate-use Programme (2011) (1)
- Randomized, double-blind, placebo-controlled proof of concept study of tasquinimod maintenance therapy in patients with metastatic castrate-resistant prostate cancer (mCRPC) who experience response or stabilization during first-line docetaxel chemotherapy. (2013) (1)
- 1011: Docetaxel (DOC) and Mitoxantron (MIT) in the Management of Hormone Refractory Prostate Cancer (HRPCA) (2007) (1)
- [The significance of palliative surgery in castration-resistant prostate cancer]. (2018) (1)
- Risk factors for significant prostate cancer in radical cystoprostatectomy specimen: A retrospective analysis. (2016) (1)
- Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND). (2022) (1)
- Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics (2022) (1)
- ANEUPLOIDY FOR CHROMOSOME 9 DETECTED BY IN SITU HYBRIDIZATION (ISH) CORRELATES WITH POOR PROGNOSIS IN PROSTATE CANCER (1999) (1)
- Do alpha-reductase inhibitors prevent prostate cancer? 2008 practice guideline from the American society of clinical oncology and American urological association. (2009) (1)
- A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results. (2012) (1)
- [Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers]. (2020) (1)
- Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al. (2016) (1)
- Hepatic effects assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials. (2018) (1)
- Personalized Follow-up in Clinical Stage I Testicular Germ Cell Tumors: The Future is Beginning. (2020) (1)
- MOLECULAR TRIGGERED THERAPY IN ANDROGEN-RESISTANT PROSTATE CANCER (2008) (1)
- Primary Retroperitoneal Lymph Node Dissection or Chemotherapy in Nonseminomas with Low-Volume Metastatic Disease: Experience Matters. (2020) (1)
- Abstracts of the 15th Congress of the European Society for Urological Research, Istanbul, October 5–7, 2000 (2000) (1)
- Sekundärmalignome nach perkutaner Radiotherapie (2017) (1)
- Is histoscanning a valid tool to detect prostate cancer in repeat biopsy? (2012) (1)
- Identification of differentially expressed genes to predict radioresistant prostate carcinomas (2019) (1)
- Extended pelvic lymphadenectomy in prostate cancer: Practice makes perfect. (2015) (1)
- Cellular fibronectin plasma and urine levels in human bladder cancer (2002) (1)
- Vimentin 3 and endothelin in prostate cancer. (2018) (1)
- 781 RADICAL CYSTECTOMY IN THE ELDERLY - FEASIBLE, BUT STRENUOUS FOR THE PATIENT (2007) (1)
- PSA flare-up in patients with hormone-refractory prostate cancer (HRPCA) receiving docetaxel-based chemotherapy: Incidence and differentiation from progressive disease. (2006) (1)
- Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG) (2022) (1)
- Prostate cancer: Sequencing AR-targeted agents might be ineffective in mCRPC (2015) (1)
- Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial. (2018) (1)
- Reverse transcription PCR assay for G250 to detect circulating tumour cells in renal cell carcinoma (RCC): Results of a prospective randomised trial (2003) (1)
- P057 PROSPER: A phase 3 study of enzalutamide in non-metastatic (M0) castration-resistant prostate cancer (CRPC) patients (2014) (1)
- 982Ketokonazol/hydrocortisone versus estramustinphosphate in the management of psa progression following primary androgen deprivation for metastatic prostate cancer (2005) (1)
- [Locally recurrent prostate cancer following radiation therapy: radical salvage prostatectomy]. (2010) (1)
- RT-PCR for AFP, HCG, GCAP and PDGF-1 To Detect Circulating Tumour Cells in Testicular Germ Cell Tumours (2002) (1)
- Re: Microsurgical testicular denervation of the spermatic cord as primary surgical treatment of chronic orchialgia. (2001) (1)
- 879 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone-refractory prostate cancer (2003) (1)
- 11c-choline-PET/CT (C-PET) versus transrectal ultrasound-guided prostate biopsies (TRUS-BP) to diagnose locally recurrent prostate cancer (PCA) following radiation therapy (RT). (2011) (1)
- Cell-free DNA as a surrogate marker in patients with CRPCA undergoing taxane-based chemotherapy. (2017) (1)
- Palliative transurethral resection in men with castration-resistant prostate cancer (CRPC): Minimally invasive procedure with minimal morbidity? (2012) (1)
- TUMOR ENUCLEATION RESECTION IN TESTICULAR GERM CELL TUMORS: LONGTERM FOLLOW-UP (1999) (1)
- IS4. Trials in Progress (2012) (1)
- [Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]. (2021) (1)
- Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy (2012) (1)
- [Retroperitoneal lymph node dissection in testicular germ cell tumours: indications, complications and special cases]. (2020) (1)
- Is there an additional benefit of Tc-99m-PSMA-guided gamma probe use for salvage lymph node dissection in recurrent prostate cancer. (2017) (1)
- Impact of human papillomavirus (HPV) infection on the outcome of perioperative treatments for penile squamous-cell carcinoma (PSCC). (2020) (1)
- Subject Index Vol. 63, 1999 (2000) (1)
- [Pitfalls and outcome of nephrectomy for patients with polycystic kidney disease: Peri- and postoperative results]. (2010) (1)
- [Optimizing treatment of advanced testicular germ cell tumors]. (2010) (1)
- Detection of prostate cancer with HistoScanning. (2011) (1)
- 675 THE COMBINATION OF DOCETAXEL AND BEVAZIZUMAB AS A SECOND-LINE THERAPY IN PATIENTS WITH HRPCA AND PSA-RELAPSE (2010) (1)
- Next Generation Sequencing (NGS) in metastatic castration resistant prostate cancer (mCRPC) to identify targets for individualized treatment: Is it feasible in daily routine? (2019) (1)
- RADIUM‐223(RAD) IN MEN WITH SYMPTOMATIC CASTRATION‐RESISTANT PROSTATE CANCER: GUIDELINE VERSUS CLINICAL REALITY.: MP53‐20 (2017) (1)
- Epigenetic inactivation of ST6GAL1 in human bladder cancer (2014) (1)
- [Microsurgical testicular denervation as therapy option in chronic testalgia]. (1997) (1)
- Prospective clinical phase-II trial on docetaxel and estramustine with or without epoeitin-α in patients with metastatic castration-resistant prostate cancer (mCRPC). (2015) (1)
- 908Palliative transurethral resection of the prostate in patients with locally advanced and metastatic prostate cancer (2005) (1)
- Management of Prostate Cancer: EAU Guidelines on Screening, Diagnosis and Treatment (2012) (1)
- [Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate]. (1997) (1)
- PENILE OXYGENE PRESSURE DURING CYCLING (1999) (1)
- Morbidity of internal ureteral stents: prospective randomized trial of polyureterane (PU) versus phosphorylcholine (PC) coated stents (2002) (1)
- Palliative transurethral resection in men with castration-resistant prostate cancer (CRPC): Minimally invasive procedure with minimal morbidity? (2012) (1)
- 1772 WHAT CAN WE LEARN FROM EXPLANTED SLINGS AND MESHES IN PELVIC FLOOR SURGERY (2010) (1)
- PSA persistence after radical prostatectomy needs more than standard therapeutic options to improve outcomes (2019) (1)
- Primary paraurethral mixed tumor (carcinosarcoma) of the vagina. A case report (1998) (1)
- Cytoreductive radical prostatectomy (CRP) in patients with prostate cancer (PCA) and low-volume osseous metastases. (2014) (1)
- 314 GEMCITABINE BASED CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED AND METASTATIC UROTHELIAL CANCER: THE ROLE OF AGE AND COMORBIDITIES ON THERAPY CAUSED MORBIDITY AND MORTALITY (2010) (1)
- 898 DOCETAXEL: RECHALLENGE AT PSA RELAPSE AFTER DOCETAXEL CHEMOTHERAPY AT HORMONE REFRACTORY PROSTATE CANCER (2010) (1)
- 68-Ga-PSMA-PET in lymph node staging in PSA recurrent prostate cancer-does the primary influence the result? (2018) (1)
- Considerations: Imaging in Prostate Cancer (2009) (1)
- Development of a risk calculator of recurrence in inguinal lymph node metastatic (ILNM) patients with surgically resected penile squamous cell carcinoma (PSCC). (2020) (1)
- Predicting vital retroperitoneal residual tumors of metastatic testicular tumor patients after chemotherapy using radiomics. (2019) (1)
- Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases after chemotherapy. (2012) (1)
- COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility (2022) (1)
- Upper Urinary Tract Decompression Using Ileal Ureter Replacement (IUR) In Comparison to Endoureteral Thermoexpandable Stent [Memokath® 051] (2017) (1)
- 674 Enzalutamide monotherapy: Results from a phase 2 study in hormone naive prostate cancer patients (2013) (1)
- [Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?]. (1997) (1)
- Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy (2012) (1)
- Treatment Efficacy of Targeted Therapies for Metastatic Renal Cell Carcinoma—A Review after Seven Years of Experience (2013) (1)
- Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer. (2021) (1)
- Radical salvage prostatectomy for locally recurrent prostate cancer after radiation therapy. (2012) (1)
- [Characterisation of DNA methylation biomarkers for bladder cancer]. (2010) (1)
- Radical prostatectomy in patients with locoregional lymph node metastases: rationale for adjuvant androgen deprivation (2002) (1)
- Ergebnisse der randomisierten Phase-III-Studie der „German Testicular Cancer Study Group“ (2009) (1)
- 11C-coline-positron emission tomography/computerized tomography (C-PET/CT) for tumor localization of locally recurrent prostate cancer after radiation therapy (2007) (1)
- Predictors for Outcome and Complications Related to Urinary Diversion (2021) (1)
- 80 RADICAL SALVAGE PROSTATECTOMY FOR RADIORECURRENT PROSTATE CANCER (2012) (1)
- Metastatic castration-resistant prostate cancer: integrating new learnings to optimise treatment outcomes. (2013) (1)
- A case of an intratesticular leyomyoma. (1999) (1)
- MP66-12 THE EXPRESSION PROFILES OF MIR-210, MIR-375, MIR-378, MIR-345, MIR-143 MIR-183 AND MIR-98 IN THE PROGRESSION OF PROSTATE CANCER FROM HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA TO METASTATIC DISEASES (2016) (1)
- PD56-03 INDEPENDENT VALIDATION OF TWO MODELS TO PREDICT NECROSIS/FIBROSIS IN POST CHEMOTHERAPY RESIDUAL RETROPERITONEAL MASSES OF PATIENTS WITH ADVANCED TESTICULAR CANCER (2019) (1)
- 1159: 11C-Coline-Positron Emission Tomography/Computerized Tomography (C-PET/CT) for Tumor Localization of Locally Recurrent Prostate Cancer After Radiation Therapy (2007) (1)
- 68-Ga-PSMA-PET in the diagnosis of local recurrent disease after radiotherapy in patients with prostate cancer. (2018) (0)
- 981PSA-Flare up in docetaxel therapy of hrpc: Incidence and clinical impact? (2005) (0)
- Comparison of ERG oncoprotein expression among matched cohorts of African American and Caucasian American patients with prostate cancer. (2012) (0)
- MP63-02 CHARACTERIZATION OF RENAL STONES USING SPECTRAL DETECTOR COMPUTED TOMOGRAPHY (2018) (0)
- 68Ga-PSMA-PET in the diagnosis of local recurrent disease after radiotherapy in patients with prostate cancer (2018) (0)
- PD63-11 RADICAL SALVAGE PROSTATECTOMY (RSP) FOR RADIORECURRENT PROSTATE CANCER (RPCA): ONOLOGICAL AND FUNCTIONAL OUTCOME OF A LARGE CONTEMPORARY SERIES (2020) (0)
- Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. (2023) (0)
- Abstract 1904: Acyl-coenzyme A synthetase 5 levels in urothelial cellines and bladder cancer tissues reflect cellular differentiation and senescence. (2013) (0)
- 788 MODIFIED HAUTMANN NEOBLADDER WITH A TWO CHIMNEY-TYPE URETEROILEAL IMPLANTATION TECHNIQUE: SIGNIFICANT DECREASE OF UPPER URINARY TRACT COMPLICATIONS (2007) (0)
- Nonguideline concordant treatment of testicular cancer. (2017) (0)
- Identifying patient profiles and mapping the patient journey across three countries in a large-scale, fully digital survey of patients with prostate cancer. (2022) (0)
- Genetic instability after radiotherapy in prostate cancer: TMRSS2-ERG fusion in salvage radical prostatectomies. (2013) (0)
- MP51-17 IS EVERY PT3A-PROSTATE CANCER (PCA) WITH POSITIVE SURGICAL MARGIN A CANDIDATE FOR ADJUVANT RADIATION (ARTX)? INDIVIDUAL RISK ASSESSMENT BASED ON A PATHOLOGICAL GLEASON SCORE PREDICTIVE MODEL – A MULTICENTRE STUDY (2014) (0)
- PD16-04 RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY IN M1A AND LOW VOLUME M1B PROSTATE CANCER PATIENTS: AN INDIRECT COMPARISON WITH THE STAMPEDE TRIAL ARM H (2020) (0)
- Targeted therapy in patients with chemorefractory, progressing testicular germ cell tumors (2021) (0)
- Treatment patterns and outcomes of patients with penile squamous-cell carcinoma (PSCC) undergoing inguinal lymph node dissection (ILND): An analysis of a multicenter contemporary database. (2020) (0)
- Need for organ preservation in postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). (2022) (0)
- Regression-tree analysis for identifying the best candidates to neoadjuvant chemotherapy in patients with clinical node-positive penile squamous-cell carcinoma (2020) (0)
- 452 Oncological outcome and complications in patients with renal cell cancer and inferior vena cava thrombus (2013) (0)
- 73: Diagnosis, Conservative and Surgical Management of Retroperitoneal Fibrosis (2004) (0)
- [Optimizing treatment of advanced urologic malignancies]. (2007) (0)
- Preoperative Parameters to Predict the Development of Symptomatic Lymphoceles after Radical Prostatectomy (2021) (0)
- Vesicouterine Fistel nach Sectio caesarea (2018) (0)
- Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister (2022) (0)
- Taxane-based chemotherapy in senior adults with metastatic castration-resistant prostate cancer (mCRPC): A prospective international registry. (2012) (0)
- Editorial: Salvage therapy in uro-oncology. (2021) (0)
- Diagnosis and Therapy of Erectile Dysfunction Following Radical Prostatectomy (2003) (0)
- Surgical management of testicular cancer patients with complex postchemotherapy residual masses: Aachen University experience. (2014) (0)
- 15 Role of radical prostatectomy in locally advanced prostate cancer (2011) (0)
- Prognostic factors in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or bicalutamide (BIC) in TERRAIN (2016) (0)
- [Management of treatment-associated complications on uro-oncological surgery]. (2020) (0)
- Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer (2022) (0)
- 653 Residual tumour resection (RTR) in advanced testicular cancer: Indication, outcome and prediction of histology (2004) (0)
- Comparison of ERG oncoprotein expression among matched cohorts of African American and Caucasian American patients with prostate cancer. (2012) (0)
- 190Surgical management of tumour thrombus in rena cell carcinoma (RCC) (2005) (0)
- Adjuvant multimodality treatment in patients with high-risk prostate cancer following radical prostatectomy: Results of a prospective clinical phase-II trial (2007) (0)
- MP18-13 VALIDATION OF EAU GUIDELINE’S PRETREATMENT RISK STRATIFICATION PARAMETERS IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2018) (0)
- 673 DOCETAXEL - RECHALLENGE AT PSA RELAPSE AFTER DOCETAXEL CHEMOTHERAPY AT HORMONE REFRACTORY PROSTATE CANCER (2010) (0)
- [Urinoma after heminephrectomy]. (2004) (0)
- Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations (2018) (0)
- Characterization of renal stones using spectral detector computed tomography (2018) (0)
- Distress screening in patients with urogenital malignancies (2017) (0)
- 922Thalidomide / interleukin-2 in metastatic kidney cancer refractory to chemoimmunotherapy (2005) (0)
- [Editorial comment on Burkhardt Soares S. et al.: retroperitoneal fibrosis]. (2007) (0)
- MP50-11 THE ROLE OF SALVAGE EXTENDED LYMPH NODE DISSECTION (LND) IN PATIENTS WITH RISING PSA AND PET/CT SCAN DETECTED NODAL RECURRENCE OF PROSTATE CANCER (2016) (0)
- Outcomes of peri-operative chemotherapy (PO-CT) for locally advanced penile squamous cell carcinoma (LA-PSCC): results from a multicenter analysis (2016) (0)
- Preoperative Imaging Techniques in Prostate Cancer (2003) (0)
- 706MO Association between human papillomavirus (HPV) infection and outcome of perioperative nodal radiotherapy for penile carcinoma (2020) (0)
- 2D and 3D/4D Perineal Ultrasound – First Experiences in Men with Urinary Incontinence after Radical Prostatectomy (2010) (0)
- 728 MANAGEMENT OF GROWING TERATOMA SYNDROME: AACHEN UNIVERSITY EXPERIENCE (2010) (0)
- MP22-03 LONG-TERM ONCOLOGIC OUTCOMES OF PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2019) (0)
- [The 20th annual conference of the Working Group on Kidney Transplantation of the Academy of German Urologists in Aachen]. (2013) (0)
- [Pro and contra: 11C choline PET in diagnosis of prostate cancer]. (2007) (0)
- Risk F actors f or R elapse i n C linical S tage I N onseminomatous Testicular G erm C ell T umors: R esults o f t he G erman Testicular C ancer S tudy G roup T rial (2003) (0)
- 691 Gemcitabine based chemotherapy of advanced bladder cancer in elderly patients (2004) (0)
- Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer: High Frequency of Lymph Node Metastases (2003) (0)
- Editorial Comment. (2019) (0)
- MP11-09 REGRESSION-TREE ANALYSIS FOR IDENTIFYING THE BEST CANDIDATES TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL NODE-POSITIVE PENILE SQUAMOUS-CELL CARCINOMA (2020) (0)
- Reply by Authors. (2020) (0)
- Posium scoring system to predict the risk to develop perioperative complications in men undergoing radical retropubic prostatectomy (RRP) (2003) (0)
- Reply by Authors. (2020) (0)
- PD57-12 THE IMPACT OF PERSISTENTLY ELEVATED PSA LEVELS ON PROGRESSION AND SURVIVAL OF PATIENTS UNDERGOING CYTOREDUCTIVE RADICAL PROSTATECTOMY FOR OLIGOMETASTATIC PROSTATE CANCER (2020) (0)
- 68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high-risk prostate cancer. (2022) (0)
- 931: Retroperitoneal Lymphadenectomy in Primary Mature Teratoma of the Testis: Is it Indicated? (2004) (0)
- 638 COMPLICATIONS OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND) IN ADVANCED NONSEMINOMATOUS GERM CELL TUMORS – FIRST RESULTS OF THE GERMAN TESTICULAR CANCER STUDY GROUP (2010) (0)
- Adjunctive surgery in postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) - is there always an oncologic benefit? (2020) (0)
- PD17-02 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: TWO-YEAR FOLLOW-UP (2020) (0)
- Managing metastatic bone disease: Three case studies : Ibandronate (2004) (0)
- 703 Loss of chromosome 14Q is a stronf predictor of progression in conventional renal cell carcinoma (2004) (0)
- Importance of magnetic resonance imaging and prostate‐specific membrane antigen PET‐CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer (2022) (0)
- DISTRESS SCREENING IN PATIENTS WITH UROGENITAL MALIGNANCIES: MP80‐03 (2017) (0)
- The significance of De-Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy (2020) (0)
- [Female urethral diverticulum with calculus formation imitating stress incontinence]. (2017) (0)
- Association of sex with oncologic outcomes in pTa bladder cancer (2021) (0)
- Validation and implementation of a mobile app decision support system for quality assurance of tumor boards. Analyzing the concordance rates for prostate cancer at a multidisciplinary tumor board of a tertiary referral centre (2020) (0)
- Vascular anomalies in patients undergoing retroperitoneal lymph node dissection. (2014) (0)
- 858PCOMPLICATIONS DURING CISPLATIN BASED PRIMARY CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER: IS THERE A NEED FOR THROMBOEMBOLIC PROPHYLAXIS. (2014) (0)
- Avoid Downplaying Side Effects Reply (2016) (0)
- Follow-Up After Radical Treatments and Relapse (2017) (0)
- Laparoskopische transperitoneale Nephrektomie und Nierenzystenresektion (2007) (0)
- Biochemichal recurrence in prostate cancer after salvage surgery in correlation to the site of reccurrent disease. (2019) (0)
- Subject Index Vol. 85, 2010 (2010) (0)
- Bilateral T-shaped Scrotoplasty as an Ancillary Technique of Staged Anterior Urethroplasty: The End Justifies the Means (2022) (0)
- Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing? (2021) (0)
- Development of a risk calculator of recurrence in inguinal lymph-node metastatic (ILNM) patients with surgically-resected penile squamous-cell carcinoma (PSCC) (2020) (0)
- In reply. (2013) (0)
- 296 DIAGNOSIS, CONSERVATIVE AND SURGICAL MANAGEMENT OF RETROPERITONEAL FIBROSIS (RPF) (2007) (0)
- PD51-11 CONCOMITANT VS STAGED LYMPHADENECTOMY IN CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: RECURRENCE PATTERNS AND SURVIVAL OUTCOMES (2022) (0)
- Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal approach (2020) (0)
- Management of Late Relapses in Metastatic Testicular Germ Cell Tumors: Still a Challenge (2021) (0)
- [Pharmacological therapy of urogenital cancer: rational routine diagnostic imaging]. (2013) (0)
- 11C‐CHOLINE VERSUS 68GA‐PSMA PET/CT SCAN FOR THE DETECTION OF NODAL RECURRENCE FROM PROSTATE CANCER: RESULTS FROM A LARGE, MULTI‐INSTITUTIONAL SALVAGE LYMPH NODE DISSECTION SERIES: MP77‐01 (2017) (0)
- Viable germ cell tumor and teratoma can be distinguished from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens by a combination of microRNA-371a-3p and 375-5p. (2022) (0)
- MP60-12 MID-TERM RESULTS OF ANTERIOR URETHROPLASTY WITH TISSUE-ENGINEERED ORAL MUCOSA GRAFT MUKOCELL® (2020) (0)
- [In Process Citation]. (2008) (0)
- What is the optimal management of nodal oligorecurrent prostate cancer? Results from a large series of patients treated with salvage lymph node dissection (2022) (0)
- [Surgical treatment of intracaval tumor relapse after radical tumor nephrectomy in locally advanced renal cell carcinoma]. (2020) (0)
- MP28-13 IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES TO PREDICT RADIORESISTANT PROSTATE CARCINOMAS (2019) (0)
- A new Prostate Cancer Surrogate Marker-Vimentin3? (2021) (0)
- Subject Index Vol. 76, 2006 (2006) (0)
- Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. (2021) (0)
- WITHDRAWN: Impact of Staging 68Ga-PSMA-11 PET scans on radiation treatment plans in patients with prostate cancer by Thomas Hope et al. (2018) (0)
- Prognostic risk factors in low stage testicular nonseminomatous germ cell tumors (NSGCT) (1997) (0)
- Contents Vol. 76, 2006 (2006) (0)
- [Metastatic apocrine adenocarcinoma of the penis: cytostatic therapy]. (2012) (0)
- Management of Residual Tumor in Testicular Cancer (2018) (0)
- Vascular Anomalies in Patients Undergoing Retroperitoneal Lymph Node Dissection (RPLND) for Testicular Germ Cell Tumours (TGCT) (2002) (0)
- [Successful start of the Cologne operation workshop]. (2017) (0)
- ANZUP Scientific Program and Pre‐Conference Meetings (2013) (0)
- [Vesicouterine fistula after caesarean section]. (2018) (0)
- 708 Dysregulation of cellular retinoic acid-binding protein (CRABP)-1 in renal cell carcinoma (2004) (0)
- 138 ADJUVANT MULTIMODALITY TREATMENT IN PATIENTS WITH HIGH RISK PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE CLINICAL PHASE-II TRIAL (2007) (0)
- 706 Cellular fibronectin plasma levels in localized and metastatic renal cell carcinoma (2004) (0)
- Extended pelvic lymphadenectomy in men undergoing radical prostatectomy - an update on > 300 cases. (2004) (0)
- [Personalised medicine in prostate cancer]. (2019) (0)
- 188 TROSPIUM CHLORIDE RELEASED FROM INTRAVESICALLY APPLIED PLGA-BASED DRUG DELIVERY DEVICES DECREASES BLADDER CONTRACTILITY IN AN ISOLATED WHOLE PIG BLADDER MODEL (2010) (0)
- 9.3 Urethrotomia interna (2006) (0)
- AdjuvantTherapy in High Risk Prostate Cancer: The Argument CON (2004) (0)
- Surgical resection of metastases in patients with urogenital malignancies. (2016) (0)
- PET tracers against the prostate-specific membrane antigen (PSMA) for localization of relapsed prostate cancer in patients with renewed increase in the prostate-specific antigen (PSA), (2016) (0)
- Seminomatous germ cell tumors are heterogenic and metastasis can be predicted based on a gene signature of the tumor invasive front. (2019) (0)
- 730 COMPLICATIONS OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND) IN ADVANCED NONSEMINOMATOUS GERM CELL TUMOURS: FIRST RESULTS OF THE GERMAN TESTICULAR CANCER STUDY GROUP (2010) (0)
- Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: A diagnostic meta-analysis (2022) (0)
- Comprehensive analysis of metastatic seminoma germ cell tumors shows divergent expression of immune-related pathways (2019) (0)
- MP11-11 VALIDATION AND IMPLEMENTATION OF A MOBILE APP DECISION SUPPORT SYSTEM FOR QUALITY ASSURANCE OF MULTIDISCIPLINARY TUMOR BOARDS (MTD) TO OPTIMIZE MANAGEMENT OF ADVANCED TESTICULAR CANCER (2020) (0)
- Expression of EGFR and HER2/neu and absence of activating mutations in patients with castration-resistant prostate cancer. (2010) (0)
- [Operative treatment of renal cell carcinoma]. (2011) (0)
- [Radical cystoprostatectomy and pelvic lymphadenectomy]. (2008) (0)
- Radical salvage prostatectomy for locally recurrent prostate cancer after radiation therapy. (2012) (0)
- Controversy: Locally advanced prostate cancer (2011) (0)
- The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer (2020) (0)
- 68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high risk prostate cancer (2022) (0)
- Management of growing teratoma syndrome (GTS): Results of the German Testicular Cancer Study Group. (2018) (0)
- Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem? (2021) (0)
- Prognostic factors for the recurrence of renal cell carcinoma after radical nephrectomy. (2006) (0)
- Validation and implementation of a mobile app decision support system for quality assurance of tumor boards. Analyzing the concordance rates for prostate cancer from a multidisciplinary tumor board of a University Cancer Center (2022) (0)
- Author reply (0)
- 762 Outcome of elderly men after transurethral resection of their prostate (2004) (0)
- [Retroperitoneoscopic nephrectomy]. (2008) (0)
- PD25-11 MULTIVISCERAL SURGERY IN MEN WITH LOCALLY ADVANCED, SYMPTOMATIC CASTRATION RESISTANT PROSTATE CANCER (2019) (0)
- Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient stratification for tailored post-operative treatments (2020) (0)
- Diagnostic accuracy of PET scan in salvage lymph node resections in patients with prostate cancer (CaP). (2013) (0)
- PD39-09 TREATMENT OF MALE STRESS URINARY INCONTINENCE WITH ADJUSTABLE SLINGS AND ARTIFICIAL URINARY SPHINCTER – FOCUS ON PATIENT SELECTION AND POSTOPERATIVE CONTINENCE STATUS (2018) (0)
- Radical Salvage Prostatectomy (RSP) for Radiorecurrent Prostate Cancer (rPCA): Onological and functional outcome of a large contemporary series (2020) (0)
- 24 Role of surgery in the management of testis cancer (2011) (0)
- Efficacy of abiraterone acetate in the treatment of castration-resistant prostate cancer: Early results from the German compassionate-use program. (2012) (0)
- INFLUENCES OF GYM EXERCISES ON THE PENILE OXYGENE PRESSURE (1999) (0)
- 390Investigation of microdeletions of testicular determining genloci SRY and AZF on chromosome YQ in patients with undescended testis (2005) (0)
- PD53-10 PREDICTING LIMITED SURVIVAL FOR PATIENTS WITH PENILE CANCER UNDERGOING INGUINAL LYMPH NODE DISSECTION (2021) (0)
- The role of lymph node dissection in patients undergoing salvage radical prostatectomy for radiation recurrent prostate cancer (2022) (0)
- Websites on Bladder Cancer: an Appropriate Source of Patient Information? (2018) (0)
- Effect of pelvic muscle exercises with electrical stimulation and biofeedback after radical prostatectomy (2002) (0)
- CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE‐NAIVE, METASTATIC PROSTATE CANCER (MPCA).: MP53‐19 (2017) (0)
- [Second neoplasms after percutaneous radiotherapy]. (2017) (0)
- MP15-10 THE ROLE OF LYMPH NODE DISSECTION IN PATIENTS UNDERGOING SALVAGE RADICAL PROSTATECTOMY (2021) (0)
- Functional and oncologic outcomes of nephron-sparing surgery (NSS) for patients with renal cell carcinoma (RCC) greater than 4 cm in diameter. (2011) (0)
- 852 Genetic pathways and new progression markers for prostate cancer defined by microsatellite allelo-typing (2004) (0)
- Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney sparing strategies: an international collaborative study (2021) (0)
- Management of Metastatic Castration-Naïve Prostate Cancer (2018) (0)
- 974: Temozolomide in the Management of Progressive Metastatic Renal Cell Cancer (RCC) Following Immunotherapy (2005) (0)
- Identification of differentially expressed genes to predict radioresistant prostate carcinomas. (2019) (0)
- Validation and implementation of a mobile app decision support system for quality assurance of tumor boards: Analyzing the concordance rates for testis cancer at a multidisciplinary tumor board of a tertiary referral center. (2020) (0)
- [Nerve-sparing radical retropubic prostatectomy and pelvic lymph node excision in prostatic carcinoma]. (2005) (0)
- Cell-free DNA ( cfDNA ) as a prognostic marker for response to taxan-based chemotherapy in prostate cancer ( PCA ) patients (2015) (0)
- Clinical accuracy of detecting recurrent prostate cancer lesions with F-18-Fluoroethylcholine or Ga-68-PSMA-HBED-CC PET/CT. (2016) (0)
- Comparing the perioperative management of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with pure seminomatous and nonseminomatous germ cell tumors (NSGCT). (2011) (0)
- Corona, higher risk for testicular cancer development? (2021) (0)
- MP76-05 VALIDATION OF THE BEST MODELS TO PREDICT PATHOHISTOLOGY IN GERM CELL TUMOR PATIENTS UNDERGOING POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (2020) (0)
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. (2019) (0)
- Tissue-engineered autologous oral mucosa graft for urethral reconstruction: Results from a national multicentre survey (2018) (0)
- Efficacy and tolerability of taxane-based chemotherapy in senior adults with metastatic castration-resistant prostate cancer (mCRPC): a prospective international registry (2012) (0)
- Prophylactic Antibiotics for Urological Procedures (1999) (0)
- MP11-08 DEVELOPMENT OF A RISK CALCULATOR OF RECURRENCE IN INGUINAL LYMPH-NODE METASTATIC (ILNM) PATIENTS WITH SURGICALLY-RESECTED PENILE SQUAMOUS-CELL CARCINOMA (PSCC) (2020) (0)
- Vier Therapieoptionen - was tun? (2021) (0)
- 11c-choline-PET/CT versus transrectal ultrasound-guided prostate biopsy to diagnose locally recurrent prostate cancer following radiation therapy. (2011) (0)
- Reply to Magdi Kirollos’ Letter to the Editor re: Axel Heidenreich, Gunnar Aus, Michel Bolla et al. EAU Guidelines on Prostate Cancer. Eur Urol 2008;53:68–80 (2008) (0)
- 1018 Cytoreductive radical prostatectomy (CRP) in men with low volume skeletal metastases – a feasibility and case-control study (2015) (0)
- What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series (2020) (0)
- EBV induced loss of sperm quality. (2021) (0)
- Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference? (2023) (0)
- Association of nonseminomatous testicular germ cell tumors with teratoma-free primaries with disease relapse and overall survival. (2022) (0)
- Which patients with Oligometastatic Prostate Cancer should be considered for Cytoreductive Radical Prostatectomy as part of a multimodal treatment? Results from a large, multi-institutional collaboration (2021) (0)
- 186: Modified Hautmann Neobladder with a two Chimney-Type Ureteroileal Implantation Technique: Significant Decrease of Upper Urinary Tract Complications (2007) (0)
- PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION (2021) (0)
- MP79-07 VALIDATION AND IMPLEMENTATION OF A MOBILE APP DECISION SUPPORT SYSTEM FOR QUALITY ASSURANCE OF TUMOR BOARDS. ANALYZING THE CONCORDANCE RATES FOR PROSTATE CANCER AT A MULTIDISCIPLINARY TUMOR BOARD OF A TERTIARY REFERRAL CENTRE (2020) (0)
- New Technology and Techniques Anterior Urethroplasty Using a New Tissue Engineered Oral Mucosa Graft : Surgical Techniques and Outcomes (2018) (0)
- 946 ADJUNCTIVE SURGERY IN MEN UNDERGOING RESIDUAL TUMOR RESECTION FOLLOWING CHEMOTHERAPY FOR ADVANCED CHEMOTHERAPY (2009) (0)
- Efficacy and safety of enzalutamide vs bicalutamide in European and North American men participating in the TERRAIN trial. (2016) (0)
- 916Temozolomide in the management of progressive metastasic renal cell cancer (RCC) following immunotherapy (2005) (0)
- MP79-02 PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION (2020) (0)
- 314: Gemcitabine Based Chemotherapy of Advanced Bladder Cancer in Elderly Patients-Investigations About the Influence of Age and Comorbidity on Therapy Caused Morbidity and Mortality (2004) (0)
- [Impact of PSA screening on mortality. PLCO project team (prostate, lung, colorectal, ovarian cancer screening trial)]. (2010) (0)
- EFFECTS AND OUTCOMES OF URETERAL STENTING PRIOR TO URETEROSCOPY VERSUS PRIMARY URETEROSCOPY IN URINARY STONE TREATMENT: MP68‐01 (2017) (0)
- Editorial Comment. (2021) (0)
- Validation of pre-treatment risk stratification parameters according to EAU Guidelines on upper tract urothelial carcinoma (UTUC) (2018) (0)
- Expression of podocalyxin-like protein (PODXL) in human testicular germ cell tumours (TGCT) (2003) (0)
- Inferior vena cava thrombus recurrence after radical nephrectomy in renal cell carcinoma. (2015) (0)
- Therapeutic Options in Hormone Refractory Prostate Cancer (2003) (0)
- 2015 Journal of Urology Consultants. (2016) (0)
- Testicular Cancer on the Web—an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines? (2017) (0)
- 516P Early relapse in seminoma is associated with reduced overall survival (2022) (0)
- Nodal-positives Prostatakarzinom (2010) (0)
- Non-guideline concordant treatment of testicular cancer (2017) (0)
- P061 Efficacy and safety of enzalutamide monotherapy in hormone-naive prostate cancer (HNPC) (2013) (0)
- 589 RADICAL SALVAGE PROSTATECTOMY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPY (2010) (0)
- Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumors of the Testis (2018) (0)
- 1013: Adjuvant Multimodality Treatment in Patients with High Risk Prostate Cancer Following RadicalProstatectomy: Results of a Prospective Clinical Phase-II Trial (2007) (0)
- [Limits of surgery in uro-oncology]. (2018) (0)
- Detection and size measurements of kidney stones on virtual non-contrast reconstructions derived from dual-layer computed tomography in an ex vivo phantom setup (2022) (0)
- Detection of prostate cancer by histoscanning. (2011) (0)
- 1871 THE ROLE OF PREVIOUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) ON THE ACCURACY OF NOMOGRAMS TO PREDICT FINAL PATHOLOGICAL STAGE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER (PCA) (2010) (0)
- PD17-08 COMPARING THE DIAGNOSTIC ACCURACY OF 68GA-PSMA AND 11C-CHOLINE PET/CTSCAN ACCORDING TO PSA LEVEL: A LARGE MULTI-INSTITUTIONAL ANALYSIS WITH HISTOLOGICAL VERIFICATION IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER (2019) (0)
- The impact of salvage prostatectomy on postoperative continence rates and patients quality of life (2018) (0)
- PD51-08 NERVE SPARING RETROPERITONEAL LYMPH NODE DISSECTION IN LOW VOLUME METASTATIC SEMINOMA (2022) (0)
- Complications during cisplatin-based primary chemotherapy in patients with testicular cancer: Is there a need for thromboembolic prophylaxis? (2014) (0)
- Editorial comment. (2013) (0)
- 1413: Radical Retropubic Prostatectomy in Patients with High Risk Prostate Cancer (2007) (0)
- Comparing the diagnostic accuracy of 68Ga-PSMA and 11C-Choline PET/CT scan according to PSA level: A large multi-institutional analysis with histological verification in patients treated with salvage lymph node dissection for recurrent prostate cancer (2019) (0)
- The impact of HistoScannin in prostate cancer detection: A sextant-specific analysis of detection and on tumor volume. (2015) (0)
- [Therapeutical options for seminomas at clinical stage I-IIA/B]. (2004) (0)
- Radical Orchiectomy and Testis Sparing Procedures for the Management of Germ Cell Tumors (2011) (0)
- In Reply. (2016) (0)
- Non-seminomatous testicular germ cell tumours with teratoma-free primaries are associated with a reduced early relapse-free and overall survival (2022) (0)
- Author Reply. (2017) (0)
- Multimodalitytreatment in advanced prostate cancer (2004) (0)
- Adult UrologyOncology: Prostate/Testis/Penis/UrethraEditorial Comment (2009) (0)
- Urological Injuries in Polytraumatized Patients (2016) (0)
- [Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data]. (2018) (0)
- POD-02.01 Detection of Prostate Cancer by HistoScanning™ (2011) (0)
- Complicated postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in advanced testicular germ cell tumours: Is it worth the efforts? (2015) (0)
- 703 IMMUNOHISTOCHEMICAL EXPRESSION ANALYSIS OF POTENTIAL MOLECULAR TARGETS FOR THE MANAGEMENT OF ANDROGEN-INDEPENDENT PROSTATE CANCER (2009) (0)
- MP73-05 NEWLY IDENTIFIED REGULATION MECHANISM IN EBV POSITIVE SEMINOMA (2019) (0)
- A Phase 1 Study of EMD 525797 (DI17E6), A Humanized Monoclonal Antibody to Human AV Integrins, in CRPC with Bone Metastases After Chemotherapy (2012) (0)
- Progression-free survival, PFS, depending on the site of lymph-node metastases in patients after salvage lymph node dissection, sLAD, in lymph node only recurrent prostate cancer. (2022) (0)
- Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology? (2020) (0)
- [Bisphosphonates in oncology]. (2007) (0)
- High-intensity focused ultrasound (HIFU) of prostate cancer - first clincal results with Focal One (R) (2015) (0)
- Seminomatous germ cell tumors are heterogenic and metastasis can be predicted based on a gene signature of the tumor invasive front (2019) (0)
- PD56-05 THE PRIMETEST TRIAL – INTERIM ANALYSIS OF A PHASE II TRIAL FOR PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN STAGE II A/B SEMINOMA PATIENTS WITHOUT ADJUVANT TREATMENT (2018) (0)
- Introduction: Technical Aspects of Radical Prostatectomy (2005) (0)
- 766PDLONG-TERM EFFICACY AND SAFETY OF ENZALUTAMIDE MONOTHERAPY IN HORMONE-NAIVE PROSTATE CANCER: 2-YEAR FOLLOW-UP. (2014) (0)
- Mature, clinical stage I testicular teratoma: retroperitoneal lymphadenetomy or surveillance? (1997) (0)
- MP46-17 THE IMPACT OF PATHOLOGICAL GLEASON SCORE ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH PATHOLOGICALLY ORGAN-CONFINED T2 PROSTATE CANCER AND POSITIVE SURGICAL MARGINS: CAN WE JUSTIFY EXPECTANT MANAGEMENT OR IS ADJUVANT RADIATION THERAPY INDICATED? RESULTS OF A MULTICENTER EUROPEAN EVALUATION (2014) (0)
- 1044 IS ROUTINELY HISTOLOGICAL PROCESSING AND EXAMINATION OF LYMPH NODE SPECIMEN IN PENILE CARCINOMA RELIABLE (2007) (0)
- Stage independent molecular detection of DNA-alterations in serum- and urine of bladder cancer patients (2002) (0)
- Current approaches to incorporation of radium-223 in clinical practice (2018) (0)
- Residual tumor resection (RTR) in advanced testicular cancer: Indication, outcome and prediction of histology. (2004) (0)
- Management of growing teratoma syndrome: Aachen University experience. (2014) (0)
- Testicular Cancer- Clinical Features, Staging and Surgical Management (2015) (0)
- Resektion der Vena jugularis interna bei infizierter Thrombose (2003) (0)
- Clinical quiz. Vesicoureteral reflux. (2000) (0)
- Multivisceral surgery in men with locally advanced, symptomatic castration-resistant prostate cancer (2019) (0)
- Multicenter analysis of serum tumor markers, treatment patterns, and relapse in patients with testicular cancer in clinical stage IS. (2020) (0)
- Predicting vital retroperitoneal residual tumors of metastatic testicular tumor patients after chemotherapy using radiomics (2019) (0)
- 194 Sacral colpopexy with concomitant burch colposuspension (2004) (0)
- Regression tree analysis to identify the best candidates for neoadjuvant chemotherapy (NAC) in patients with clinically lymph node-positive penile squamous cell carcinoma (PSCC). (2020) (0)
- Significant differences in radiotelemetric monitoring of real-time filling cystometry in barn housing versus metabolic cage in Göttinger Minipigs in a long-term trial (2013) (0)
- Subject Index Vol. 62, 1999 (1999) (0)
- 2555 Impact of enzalutamide (ENZA) compared with bicalutamide (BIC) on quality of life (QoL) in men with metastatic castration-resistant prostate cancer (mCRPC): Results from the TERRAIN study (2015) (0)
- 128 Cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen: Interim analysis on treatment associated side effects resulting from a compassionate-use programme (CUP) (2012) (0)
- Organ preserving surgery in testicular cancer - long-term results of the German Testicular Cancer Study Group (2005) (0)
- 829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact? (2005) (0)
- Radical prostatectomy in oligo-metastatic disease (2016) (0)
- Prostate Cancer : diagnosis and surgical treatment (2003) (0)
- Radical prostatectomy should not be performed in low risk prostate cancer (2017) (0)
- 512MO Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: An analysis of the IGCCCG Update database (2022) (0)
- Validation of the two best models to predict “benign” pathohistology in patients with advanced nonseminomatous germ cell tumors (NSGCT) undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). (2020) (0)
- [Painless ESWL by cutaneous administration of Vaseline]. (1995) (0)
- Intussusception of the reconstructed bladder neck leads to less extravasation and better continence rate after radical prostatectomy (2003) (0)
- How to avoid suboptimal treatment in testicular cancer (2017) (0)
- Cytoreductive radical prostatectomy: who benefits from the surgical approach? (2023) (0)
- Re: Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. (2018) (0)
- MP15-05 PREOPERATIVE PARAMETERS TO PREDICT THE DEVELOPMENT OF SYMPTOMATIC LYMPHOCELES AFTER RADICAL PROSTATECTOMY (2021) (0)
- Author Response on the Manuscript Titled “Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer” (#URL-D-17-01121) (2017) (0)
- The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD) (2017) (0)
- [Metastasectomy for renal cell cancer]. (2012) (0)
- 132 C-CHOLINE-PET/CT VERSUS TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY TO DIAGNOSE LOCALLY RECURRENT PROSTATE CANCER FOLLOWING RADIATION THERAPY (2011) (0)
- Editorial Comment on: Laparoscopic Retroperi- toneal Lymph Node Dissection: Does It Still Have a Role in the Management of Clinical Stage I (2008) (0)
- O10 Enzalutamide, an androgen receptor signaling inhibitor, improves overall survival, time to first skeletal related event and pain (2012) (0)
- En-bloc vs conventional resection of primary bladder tumor (EBLOC): a multicenter, open-label, phase 3 randomised controlled trial (2022) (0)
- Non-guideline concordant treatment of testicular cancer patients is associated with a significantly reduced event-free survival (2019) (0)
- Natural history of patients affected by nodal recurrence from prostate cancer treated with salvage lymph node dissection without additional treatments (2018) (0)
- 126 PREVALENCE, SEVERITY, AND CHRONICITY OF PAIN AND GENERAL HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH LOCALIZED PROSTATE CANCER (2007) (0)
- Is transurethral resection of large prostatic adenomas justified (2002) (0)
- [Systemic therapy of metastatic renal cell carcinoma]. (2006) (0)
- 607 FEMTOSECOND LASER BASED HIGH RESOLUTION OPTICAL COHERENCE TOMOGRAPHY FOR DETECTION OF CYSTITIS CYSTICA IN HUMAN BLADDER - A FEASIBILITY STUDY (2010) (0)
- 7013 POSTER DISCUSSION A Phase 1 Study of DI17E6, an Antibody Targeting AV Integrins, in Progressive Castrate-resistant Prostate Cancer With Bone Metastases (mCRPC) After Chemotherapy (2011) (0)
- 1478 THE ROLE OF PREVIOUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) ON THE ACCURACY OF NOMOGRAMS TO PREDICT FINAL PATHOLOGICAL STAGE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER (PCA) (2011) (0)
- Frequency and prognostic significance of the PSA flare-up phenomenon in men with castration-resistant prostate cancer (CRPC) who undergo docetaxel-based chemotherapy. (2012) (0)
- PD34-05 IMPACT OF PREVIOUS WHOLE PELVIS RADIATION THERAPY IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER NODE-ONLY RECURRENCE: EVALUATION OF SURGICAL, PATHOLOGICAL, AND ONCOLOGICAL OUTCOMES (2021) (0)
- PD35-03 THE SIGNIFICANCE OF DE-RITIS RATIO IN PATIENTS WITH RADIATION-RECURRENT PROSTATE CANCER UNDERGOING SALVAGE RADICAL PROSTATECTOMY (2021) (0)
- – Prostate Cancer – Editor ’ s Choice Managing Nonmetastatic Castration-resistant Prostate Cancer (2019) (0)
- MP49-01 PREDICTORS OF THROMBOSIS IN TESTICULAR CANCER DURING PLATINUM-BASED CHEMOTHERAPY (2019) (0)
- Inclusion of corrected calcium and creatinine levels in a novel nomogram for prediction of pathologically localized prostate cancer. (2016) (0)
- Efficacy and Safety of Inhaled Recombinant Interleukin-2 in High-Risk Renal Cell Cancer Patients Compared with Systemic Interleukin-2 : an Outcome Study ( renal cancer / lung metastasis / aerosol / interleukin-2 / inhalation / local therapy ) (2004) (0)
- Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2020) (0)
- Exenterative surgery to improve quality of life on men with locally advanced, symptomatic castration-resistant prostate cancer. (2020) (0)
- Radical retropubic prostatectomy in patients with high risk prostate cancer (2007) (0)
- NON‐GUIDELINE CONCORDANT TREATMENT OF TESTICULAR CANCER: PD53‐01 (2017) (0)
- [Pro and contra pelvic lymphadenectomy in prostatic carcinoma]. (2004) (0)
- Organ Sparing Tumour Resection in Testicular Germ Cell Tumours (TGCT) — Long-term Follow-up (2002) (0)
- 9.6 Perkutane Nephrolitholapaxie (PCNL) (2014) (0)
- Contents Vol. 85, 2010 (2010) (0)
- Subject Index Vol. 71, 2003 (2003) (0)
- First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis. (2020) (0)
- IGCCCG-Fehlklassifikation (International Germ Cell Consensus Classification) durch zeitlich inkorrekte Interpretation der Serumkonzentration der Tumormarker bei metastasierten testikulären Keimzelltumoren (2021) (0)
- MP10-10 SURGICAL MANAGEMENT OF TESTICULAR CANCER PATIENTS WITH COMPLEX POSTCHEMOTHERAPY RESIDUAL MASSES: SINGLE CENTRE EXPERIENCE (2014) (0)
- Identifying the optimal candidate for salvage lymph node dissection for nodal recurrence of prostate cancer: Results from a large, multi-institutional analysis (2017) (0)
- 8.4 Orchidopexie (2014) (0)
- [Influence of the working model on the education of young urologists : Education through the ages]. (2021) (0)
- The first results of targeted screening with a distress thermometer and initiation of psycho-oncological care of cancer patients. (2015) (0)
- MP22-06 IMAGING TARGETED TREATMENTS VERSUS EXTENDED SALVAGE LYMPH NODE DISSECTION FOR PATIENTS WITH A SINGLE NODAL RECURRENCE OF PROSTATE CANCER: A COMPARATIVE ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2019) (0)
- Is online patient information on bladder cancer websites in line with the EAU guidelines (2018) (0)
- PD43-12 BIOMARKS FOR KIDNEY CANCER DIFFERENTIATION (2022) (0)
- 419 Individual risk for biochemical recurrence in localized prostate cancer with positive surgical margins: A multicentre study (2014) (0)
- Prognostic risk factors for survival following adjuvant chemotherapy for locally advanced urothelial bladder cancer (2006) (0)
- PD22-04 AUGMENTATION URETHRAL RECONSTUCTION USING TISSUE-ENGINEERED ORAL MUCOSA GRAFT MUKOCELL® (2019) (0)
- MP79-16 LONG-TERM RESULTS OF CYTOREDUCTIVE RADICAL PROSTATECTOMY IN MEN WITH HORMONE-NAIVE, LOW VOLUME METASTATIC PROSTATE CANCER(MHNPCA) (2020) (0)
- Novel surgical techniques in urology. (2020) (0)
- Active surveillance and watchful waiting for localized prostate cancer in elderly patients >70 years in a community-based setting: Results from the HAROW study. (2017) (0)
- 514P Nerve sparing retroperitoneal lymph node dissection for clinical stage IIA/B seminomas: A clinical phase II trial (2022) (0)
- Next generation sequencing (NGS) in metastatic castration resistant prostate cancer (mCRPC) to identify targets for individualized treatment – is it feasible in daily routine? (2019) (0)
- 601 Complicated postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in advanced testicular germ cell tumours – is it worth the efforts? (2015) (0)
- Fluorescent microsatellite analysis (MSA) identifies D3S2447 as a new seminoma specific marker (2003) (0)
- Local treatment of metastasis improves oncological outcome in men with prostate cancer undergoing cytoreductive radical prostatectomy (cRP) for metastatic prostate cancer (mPCA) (2018) (0)
- [Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy]. (2013) (0)
- The importance of imaging studies to monitor treatment with novel AR-targeted agents in metastatic castration resistant prostate cancer (mCRPC) (2017) (0)
- 345 Radical salvage prostatectomy for locally recurrent prostate cancer after low dose brachytherapy (2012) (0)
- MP82-06 NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY (2020) (0)
- Urethral reconstruction using tissue-engineered oral mucosa graft MukoCell® in onlay technique (2018) (0)
- THE IMPORTANCE OF IMAGING STUDIES TO MONITOR TREATMENT WITH NOVEL AR‐TARGETED AGENTS IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC).: PD24‐04 (2017) (0)
- 9.4 Urethrotomia interna (2014) (0)
- MP16-03 ONCOLOGICAL AND FUNCTIONAL OUTCOME OF RADICAL SALVAGE PROSTATECTOMY IN A LARGE CONTEMPORARY SERIES (2018) (0)
- [Second-line thalidomide/IL-2 therapy in metastatic kidney cancer--results of a pilot study]. (2006) (0)
- Thromboembolic complications and prophylactic anticoagulation in advanced testicular germ cell tumours (2020) (0)
- 608 FUNCTIONAL AND ONCOLOGICAL OUTCOMES OF NEPHRON-SPARING SURGERY (NSS) FOR PATIENTS WITH RENAL CELL CARCINOMA (RCC) > 4 CM IN DIAMETER (2011) (0)
- Oncological and functional outcomes of cytoreductive radical prostatectomy (cRP) in men with metastatic hormone-naive prostate cancer (mhnPCA) (2020) (0)
- No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients (2011) (0)
- Analysis of three models to predict pathohistology in patients undergoing postchemotherapy RPLND for (pcRPLND) advanced nonseminomatous germ cell tumors (NSGCT). (2019) (0)
- The expression profiles of miRNAs in the progression of prostate cancer from high-grade prostatic intraepithelial neoplasia to metastatic diseases. (2016) (0)
- Editorial comment. (2014) (0)
- 322: Diagnostic Accuracy of Sentinel Lymph Node Scintigraphy (SLNS) in Patients Undergoing Radical Prostatectomy for Prostate Cancer (2007) (0)
- Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy (2020) (0)
- The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study (2020) (0)
- Jetpack Envy The Literary Merits of the Idea in SF (2014) (0)
- Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue (2022) (0)
- [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy]. (2004) (0)
- MP73-13 COMPREHENSIVE ANALYSIS OF METASTATIC SEMINOMA GERM CELL TUMORS SHOWS DIVERGENT EXPRESSION OF IMMUNE-RELATED PATHWAYS (2019) (0)
- Erratum to “Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia” [Clinical Biochemistry 45 (2012) 7–11] (2012) (0)
- 400Outcome of radical prostectomy in patients with prostate cancer and preoperative gleason score ≥ 8 (2005) (0)
- Validation and implementation of a mobile app decision support system for quality assurance of multidisciplinary tumor boards (MTD) to optimize management of advanced testicular cancer (2020) (0)
- [Innovative treatment options in the management of prostate cancer]. (2021) (0)
- [Pelvic exenteration in patients with locally advanced, symptomatic castration-resistant prostate cancer]. (2021) (0)
- Evaluation of (18F) FDG-PET-CT for preoperative lymph-node staging of bladder cancer. (2012) (0)
- Detection of prostate cancer with histoscanning: A retrospective analysis in 85 patients. (2012) (0)
- Feasibility and oncologic outcome of salvage surgery in isolated seminal vesical remnants after radical prostatectomy (2020) (0)
- Histopathological and biological prognostic risk factors in low stage testicular nonseminomatous germ cell tumors (1999) (0)
- Long-term efficacy and safety of enzalutamide (ENZ) monotherapy in hormone-naïve prostate cancer (HNPC): 3-year, open-label, follow-up results. (2017) (0)
- MP64-11 PROGNOSTIC IMPACT OF GLEASON GRADE AT THE MARGIN IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2021) (0)
- [Workshop for surgical skills in Cologne by GeSRU]. (2016) (0)
- First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment (2022) (0)
- Treatment of the primary in metastatic prostate cancer. (2020) (0)
- IS PROSTATE CANCER AT YOUNG AGE BIOLOGICALLY MORE AGGRESSIVE THAN IN ELDERLY MEN (2008) (0)
- TABLES FOR PREDICTING POST-PROSTATECTOMY INCONTINENCE (PPI) (2006) (0)
- 1416 CONTACTLESS ENDOSCOPIC MEASUREMENT OF URINARY BLADDER WALL PERFUSION (2010) (0)
- MP15-03 PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN PATIENTS TREATED WITH SALVAGE RADICAL PROSTATECTOMY FOR RADIATION-RECURRENT PROSTATE CANCER (2022) (0)
- The role of cytoreductive radical prostatectomy (cRP) in men with hormone-sensitive, metastatic prostate cancer (mPCA). (2017) (0)
- MP15-07 ANALYSIS OF PERIOPERATIVE COMPLICATIONS IN PATIENTS WITH PROSTATE CANCER BASED ON EXTENSION OF PELVIC LYMPH NODE DISSECTION (2021) (0)
- PD42-06 SALVAGE RADICAL PROSTATECTOMY (SRP) FOR RADIORESISTANT PROSTATE CANCER (PCA): OUTCOME ANALYSIS OF 2 TERTIARY REFERAL CENTRES (2018) (0)
- PD16-02 ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IN MEN WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER (MHNPCA) (2020) (0)
- MP46-10 PROSPECTIVE RANDOMIZED CLINICAL PHASE-III TRIAL OF LIMITED VS EXTENDED PELVIC LYMPHADENECTOMY IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER (PCA) – FIRST DESCRIPTIVE RESULTS (SEAL, AUO AP 55/09) (2014) (0)
- MP37-20 SURGICAL MANAGEMENT OF THE GROWING TERATOMA SYNDROME: A MULTICENTER STUDY (2018) (0)
- Reliability of modern imaging studies for detection and final pathohistological stage in men undergoing radical salvage prostatectomy (RSP) for radiorecurrent prostate cancer (rPC) (2020) (0)
- Augmentation urethral reconstuction using tissue-engineered oral mucosa graft MukoCell® (2019) (0)
- PD63-02 RELIABILITY OF MODERN IMAGING STUDIES FOR DETECTION AND FINAL PATHOHISTOLOGICAL STAGE IN MEN UNDERGOING RADICAL SALVAGE PROSTATECTOMY (RSP) FOR RADIORECURRENT PROSTATE CANCER (RPC) (2020) (0)
- CLINICAL EFFICACY AND SAFETY OF TRIPTORELINE PAMOATE IN THE MANAGEMENT OF ADVANCED PROSTATE CANCER IN 1432 PATIENTS – RESULTS OF A PROSPECTIVE NON- INTERVENTIONAL SURVEILLANCE STUDY (2008) (0)
- 434 DEVELOPMENT OF A NOVEL TUBULAR SCAFFOLD FOR THE DEVELOPMENT OF AN ARTIFICIAL URETER (2010) (0)
- Sind seminomatöse Hodentumore heterogen (2019) (0)
- [Feasibility of targeted therapy based on immunohistochemical expression analysis in androgen-independent prostate cancer]. (2008) (0)
- 9.5 Perkutane Nephrolitholapaxie (2006) (0)
- miRNA expression profiles in high-grade prostatic intraepithelial neoplasia. (2016) (0)
- The Current Status of Kidney Cancer Urine Markers – A systematic review (2022) (0)
- Prognostic value of Gleason score at positive surgical margin in prostate cancer. A systematic review and meta-analysis (2020) (0)
- P060 Enzalutamide monotherapy in patients with hormone-naive prostate cancer: 1-year extended follow-up of a Phase 2 study (2014) (0)
- 925: Risk-Adapted Treatment is Not Superior to Surgery – A Quality of Life Analysis of the German Prospective Multicenter Trial in Clinical Stage I NSGCT (2004) (0)
- Contents Vol. 71, 2003 (2003) (0)
- Predicting overall survival (OS) in patients (pts) with penile squamous cell carcinoma (PSCC) undergoing regional lymph node dissection (LND) ± multimodal therapy. (2019) (0)
- 744 ABSENCE OF ACTIVATING MUTATIONS OF EGFRAND HER-2/NEU AS PREDICTIVE MARKERS FOR RESPONSE TO TYROSINE-KINASE INHIBITORS IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER (2010) (0)
- Stage III Germ Cell Cancer (2019) (0)
- AMIFOSTINE AS PROTECTIVE AGENT IN CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER CANCER (1999) (0)
- Adjuvant immunotherapy after cystectomy for MIBC patients: Lessons learned from the phase II clinical trial ‘Magnolia’ (2018) (0)
- No Beyer et al consensus Ann Oncol 2012 (2012) (0)
- Urological Injuries in Polytrauma (2011) (0)
- Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND) (2022) (0)
- SURGICAL STRATEGIES FOR UROLOGICAL MALIGNANCIES OF THE RETROCRURAL AREA (2006) (0)
- “ACTIVE SURVEILLANCE” IN THE EVERYDAY CARE: RESULTS FROM HAROW‐A PROSPECTIVE, NON‐INTERVENTIONAL STUDY WITH A MEAN FOLLOW‐UP OF 66.7 MONTHS.: MP43‐09 (2017) (0)
- Management of positive lymph nodes following radical prostatectomy. (2019) (0)
- [Does robotic radical cystectomy affect oncological outcomes in bladder cancer patients?] (2022) (0)
- Cell-free DNA as a prognostic marker for response to taxan-based chemotherapy in patients with prostate cancer (CaP). (2013) (0)
- [Preoperative pain in urological patients scheduled for surgical intervention : Incidence, severity and chronicity]. (2009) (0)
- ACTIVE SURVEILLANCE IN LOW-RISK PROSTATE CANCER: HOW RELIABLE ARE PREOPERATIVE DIAGNOSTICS? (2008) (0)
- Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review (2022) (0)
- [Hypogonadism - testosterone replacement therapy after prostate cancer?]. (2014) (0)
- Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program (2019) (0)
- Risk-Adapted Management of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumours (2006) (0)
- [Immunotherapy for metastatic prostate cancer: do we really need this?]. (2012) (0)
- Editorial Comment. (2019) (0)
- Detection of prostate cancer with histoscanning: A retrospective analysis in 85 patients. (2012) (0)
- [The "German Testicular Cancer Study Group" (GTCSG) as an example of successful interdisciplinary cooperation]. (2007) (0)
- MP61-17 CELL-FREE DNA AS A PROGNOSTIC MARKER FOR RESPONSE TO TAXAN-BASED CHEMOTHERAPY IN PROSTATE CANCER (CAP) PATIENTS (2015) (0)
- The role of reference pathology to assess MRI-TRUS fusion prostate biopsies in a tertiary referral center. (2018) (0)
- Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Clinical Implications for multi-modal therapy (2021) (0)
- Functional Pelvic Floor Magnetic Stimulation in the treatment of Urinary Incontinence, Pelvic Pain Symptoms and Stool smearing (2009) (0)
- MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL (2022) (0)
- 867 Frequency and prognostic significance of flare-up phenomenon in castration resistant prostate cancer (CRPC) treated with docetaxel (2014) (0)
- Teratomatous Elements in Orchiectomy Specimens Are Associated with a Reduced Relapse-Free Survival in Metastasized Testicular Germ Cell Tumors (2020) (0)
- PD54-12 68GA-PSMA PET/CT FOR PREOPERATIVE LYMPH NOSDE STAGING OF HIGH RISK PROSTATE CANCER (2022) (0)
- 661: Partin Tables do not Adequately Predict the Risk of Lymph Node Involvement in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer (2006) (0)
- Evaluation of the state of health of patients with localized prostate cancer (cT1-cT2) compared to the normal population. (2010) (0)
- Reply by Authors. (2021) (0)
- 429: Genetic Pathways and New Progression Markers for Prostate Cancer Defined by Microsatellite Allelotyping (2004) (0)
- Oncological outcome of radical salvage prostatectomy in a large contemporary series (2018) (0)
- 941 Management of intracaval recurrence of renal cell cancer with thrombus formation (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Axel Heidenreich?
Axel Heidenreich is affiliated with the following schools:
